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ABSTRACT
Aqueous Solvation Method for Recombinant Spider Silk Proteins

by

Justin A. Jones, Doctor of Philosophy
Utah State University, 2015

Major Professor: Randolph V. Lewis
Department: Biology

Two major hurdles face the production of recombinant spider silk protein (rSSp)
based materials. First, the production of sufficient quantities of rSSp has proven difficult
due to their highly repetitive nature and protein size (>250kDa). Secondly, rSSp and
native silks are practically insoluble in water based solutions, necessitating the use of
harsh organic solvents that can remain in the material after production. While others
are working on solving production problems, this dissertation demonstrates a novel
aqueous solubilization method that is rapid (<1 minute) and results in near 100%
solubilization of the rSSp. From this new solubilization method films, foams, gels
(hydrogels and lyogels), adhesives, coatings and fibers have been produced as well as
the previously unreported sponge. All of these novel materials were derived from
entirely aqueous solutions with and without minor additives to influence the final
physical state of the rSSp.
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PUBLIC ABSTRACT
Aqueous Solvation Method for Recombinant Spider Silk Proteins

by

Justin A. Jones, Doctor of Philosophy
Utah State University, 2015

Major Professor: Randolph V. Lewis
Department: Biology

Spider silk is a remarkable material that has recently garnered significant
international interest due to its broad applicability and natural composition. Spider silk
fibers demonstrate unparalleled mechanical properties and their biocompatibility will
allow them to replace products currently on the market such as fibers, threads and
sutures that are made from traditional polymers. As spiders cannot be farmed, an
emphasis in the Lewis lab is being placed on producing recombinant spider silk proteins
(rSSP) in a variety of hosts, including alfalfa, goats, silkworms and Escherichia. coli. To
this end, alfalfa, goats and silkworms are being generated with unique rSSP’s that will
improve the properties of the spun fiber as well as their recovery. A new fermentation
facility is being constructed for the pilot-scale production of rSSP in E. coli. Novel
plasmids and fermentation conditions are being developed to achieve maximum levels
of production in this new facility. Recently, a new custom-engineered fiber spinning
device was installed in the laboratory that allows for precise control of the process from
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any point during the fibers production. With this device, advancements in fiber
formation were achieved with rSSP spun utilizing both 1,1,1,3,3,3hexafluoroisopropanol (HFIP) dopes and a novel method of spinning rSSP’s from
primarily water-based solutions. Films from both HFIP and aqueous-based rSSP’s were
produced and a method for improving their mechanical properties was devised. Work
has also begun on developing rSSP foams, hydrogels, lyogels and spray coatings.
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CHAPTER 1
INTRODUCTION

In today’s world of rising population and pollution levels, there is a need to
replace synthetic materials with naturally derived alternatives. Alternatives that
maintain or improve material performance but that are also produced using green
methods and that are readily reduced in the environment to their non-polluting
components. Spider silk is uniquely situated to fulfill these requirements and, due to its
unique mechanical abilities, spider silk could also be utilized in entirely new material
applications. Spider silk has the potential to alter the materials landscape.
Table 1: Mechanical property comparison of spider silks and common natural and synthetic
material. 1,2,3,4
Material
Strength (MPa)
Strain (%)
Toughness (KJ/kg)
Major Ampullate silk
Minor Ampullate silk
Flagelliform
Tubiliform silk
Bombyx mori silk
Kevlar 49
Rubber
Tendon
Bone

4000
1000
1000
1000
600
3600
50
150
160

35
5
>200
20
20
5
850
5
3

400
30
400
100
60
30
80
5
3

Spider silks have long been admired for their physical properties (Table 1). High
energy to break, biocompatibility and biodegradation5 are hallmark properties of the
fibers. Recent research has proven that natural spider silk is as conductive as copper.6
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Given this remarkable set of properties, extensive effort has been made to produce
recombinant spider silk proteins (rSSP).
Spiders produce six different types of silk fiber and one glue. All six silk fibers and
the glue are used in one or multiple phases of web development, reproduction or prey
capture. Major ampullate silk is the most studied of all of the silk fibers and is used as a
life-line for the spider as well as a structural component of the web.7 Orb-weaving
spiders lay down a line of major ampullate silk as they move about, much in the same
way as a climber uses a belaying line. If the spider falls, they need a robust fiber to
arrest their fall without causing damage to the spider. Dragline or major ampullate silk
is uniquely suited to that role with 35% elasticity and a tensile strength similar to Kevlar

Figure 1: Diagrammatic representation of a spider, their silk protein-producing glands and
resulting fiber or glue. Figure originally prepared by Dr. Michael Hinman and reproduced
with his permission.
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(Table 1). In its role as the structural component of the web (Figure 1), dragline needs
to be robust and flexible enough to resist wind and prey damage. With its remarkable
set of mechanical properties, it is well suited to that task.
Major ampullate silk is comprised of two proteins, major ampullate silk protein 1
(MaSp1)7 and major ampullate silk protein 2 (MaSp2),8 in approximately an 80:20 ratio.
Given that there is a defined ratio of MaSp1 to MaSp2 in dragline silk, there must be a
strong evolutionary reason. The mechanical properties of the fiber are that reason, and
it is now understood that the two proteins contribute different structures in the fiber
that, when combined, allow for the mechanical properties observed (Figure 2). MaSp2
has proline in its amino acid sequence that is used to make a β-spiral structure
analogous to a slinky as well as a linker region

-sheet structure. MaSp1 is devoid

of proline, and its structures are largely β-sheet and the stiff, rod like glycine-II helix.
Both MaSp’s contain highly conserved N- and C- termini.9,10 The C-termini has
been suggested to act as a molecular switch in the conversion of the protein from a
liquid crystal state within the gland to a fiber by maintaining the secreted protein in a
micellar like structure.9,11,12 The N-termini contains the secretion signal to transport
the protein from the tall columnar epithelial cells into the lumen of the gland, where it
can be utilized for fiber formation.13 For the spider, the conserved N- and C-termini are
essential for spinning a fiber, given their roles in solubility and secretion. However, to
produce these proteins synthetically, they are not required.14
Minor ampullate silk fiber comprises the auxiliary spiral of the web and acts as a
temporary scaffold during web construction. Minor ampullate is also comprised of two
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proteins, MiSp1 and MiSp2.15 Both are devoid of proline and mechanically they have
less extensibility than the proline-containing major ampullate silk fiber. The
predominant amino acid motifs are the poly-GA and poly-A β-sheet conferring
sequences, as well as the GGX motif conferring the glycine-II helix (Figure 2).16 MiSp’s
are also very large proteins, 315kDa and 275kDa respectively, much like the MaSp’s.
Flagelliform silk fibers are involved in prey capture. With 300% elasticity and an
energy-to-break similar to major ampullate silk, it is uniquely suited to this task.
Flagelliform’s predominant amino acid motif is GPGXX, which forms a beta-turn. When
several of these motifs are strung together, they form a beta-spiral (Figure 2).17 The
beta-spiral, a similar structure found in MaSp2, acts like a slinky and the high proportion
of this amino acid motif, and consequent structure, allows flagelliform to stretch to
300% of its original length and return. However, prey capture cannot be attributed to
only flagelliform, as high elasticity would invoke a trampoline like effect on any prey
flying into the web. The prey would hit the web, the flagelliform would absorb the
impact and arrest the forward progress, and the prey would then be ejected from the
web. In order to trap the insect/prey, spiders use the single non-fiber glue protein from
the aggregate gland to trap the insects in their web once flagelliform has arrested the
prey’s progress.
Aggregate silk is one of the least studied of all the silk proteins. Choresh et al.
demonstrated that aggregate was, in fact, two proteins coded from opposite strands of
the same DNA sequence.18 Aggregate is the only silk protein that is post-translationally
modified with carbohydrates, and it shares a strong sequence similarity to chitin binding
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proteins.18 This is a highly sophisticated protein that is uniquely suited to its role as a
glue protein that retains captured insects in the web.
Aciniform silk is produced to swath prey as well as to line the egg sacs of spiders.
When aciniform silk was mechanically tested and compared to dragline silk, it was 50%
stronger in terms of energy to break.19 This is a remarkable feat, as the silk is largely
devoid of the poly-GA and poly-A repeats that infer the strength providing crystalline
regions of major and minor ampullate silk proteins.
Piriform silk fibers function to attach other fibers to surfaces. Many piriform
fibers are laid down over the top of another fiber, in effect lashing the silk to virtually
any surface. Piriform anchors the web to the substrate that it is built around and also
anchors the spider’s dragline silk. Piriform is unique from an amino acid perspective in it
has exceptional motifs that contain proline.20
Tubuliform silk fiber is used to create the egg case that spiders lay their eggs in,
and it is unusual in several ways. The first is that it is the only “seasonal” silk and is
produced in the fall when spiders are ready to lay their eggs. The fiber is stiff and lacks
the high glycine content seen in almost all other silk fibers.21,22 In place of glycine,
tubuliform employs serine, similar in composition to the Bombyx mori silk fiber.
When comparing the mechanical properties of the various fibers, what becomes
immediately apparent is that major and minor dragline silks are relatively stiff and are
uniquely suited to their functions in spider survival and web development. Flagelliform,
aciniform and piriform are all very strong fibers that have a much higher degree of
extensibility or elasticity than either major or minor ampullate. In fact, the extensibility
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of aciniform is responsible for its higher energy to break than both major and minor
ampullate silks. Energy to break is a measure of the area under the stress-strain curve,
and increased extensibility provides for a greater area, even with the reduced tensile
strength (true stress).23 Further, the fibers can be grouped into three categories by their
mechanical properties relating to their function in the spider’s life cycle (survival and
web development, prey capture, reproduction). Stiffer and stronger fibers are utilized
in survival (major ampullate), web development (major and minor ampullate) and
protecting eggs from predators (tubuliform) and cushioning them (aciniform) while
highly elastic silk (flagelliform) and glue (aggregate) is used for prey capture.
A spider spins silk from water based solutions.24 Specialized tall columnar
epithelial cells produce and secrete protein into the lumen of the gland.25 The protein
solution is maintained as a viscous liquid crystal in the gland without precipitating or
prematurely solidifying.26,27,28 This is largely due to the silk orientating in a micellar-like
structure in the gland.11 The C-terminus of the major ampullate silk has a membranespanning-like structure of alternating hydrophobic and hydrophilic domains. The
hydrophilic domains comprise the outer layer of the micelle that is in contact with
water, while the hydrophobic domains are buried in the interior of the structure. 11 The
liquid crystal only begins to solidify and form a fiber when a spider demands new silk
fiber by pulling fiber from its spinnerets. The pulling force draws the soluble silk protein
from the lumen into the neck of the gland, inducing a shear force that breaks open the
micelles and exposes the hydrophobic repetitive regions to water. This induces the
formation of β-sheets, as well as other structures, and transforms the liquid crystal silk
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protein into a fiber.29 As the forming fiber travels down the duct of the gland towards
the spinneret, other mechanisms of fiber formation have been proposed, such as the
removal of ions and a slight pH drop.11 However, based on our experience, if a spider is
carefully dissected and the major ampullate glands removed, the gland can be broken
open using forceps and a fiber can be pulled directly from the luminal contents. From
that observation, we begin to understand the absolutely necessary components to
produce a fiber; spider silk protein solubilized in water and shear force to break open
the micellar-like structures and align the protein molecules. Mimicking this process has
been difficult utilizing rSSP’s, primarily due to their almost complete insolubility in
water, necessitating the use of 1,1,1,3,3,3,-hexafluoroisopropanol, a very harsh organic
solvent.
Spiders’ silk cannot be harvested for industrial purposes such as sutures or
replacement tendons and ligaments. Spiders are both territorial and cannibalistic,
making it impossible to farm sufficient quantities of spiders and collect silk fiber. This
necessitates the production of spider silk protein in other organisms and then spinning
the rSSP into fibers. However, the properties that give native spider silk fibers their
remarkable mechanical properties also predispose the rSSPs solubility problems. The
vast majority of rSSPs are insoluble in water due to their β-sheet content (due to glycine
and alanine) and general hydrophobicity, providing a tendency to aggregate and
precipitate into water insoluble forms. rSSPs are conventionally dissolved in a very
harsh organic solvent HFIP to create “dopes” that can be used to create fibers, films,
gels, and foams, and electrospun into fibers and mats.30,31 HFIP has been widely used
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and accepted as it is the only solvent that: 1) dissolves rSSPs at high concentrations (30%
w/v) providing uniformity between various groups testing data, 2) is sufficiently volatile
and miscible to be removed rapidly from the forming fiber, and 3) does not interfere
with fiber formation. In addition, rSSPs are generally insoluble in aqueous solutions after
purification, necessitating an organic solvent that meets the criteria outlined in 1-3.
There are significant problems with solvating rSSPs in HFIP or other organic
solvents at an industrial scale. HFIP is toxic32 to human health and to the environment
and has a high likelihood of having a cytological effect due to HFIP residue in spun fibers
or films.33 The cost of purchasing HFIP ($100/g) renders it impractical as a solvent to
produce synthetic fibers for medical devices on a large scale. The cost of protecting the
environment and workers from exposure would drive the cost of materials produced to
economically unfeasible levels. All of these negative aspects have a dramatic economic,
ecological and pathological disincentive to produce rSSP based products using HFIP as a
solvent. To date however, there is no working process to efficiently dissolve rSSPs in
any other solvent that would be less toxic and costly.
There are some notable outliers to solvating rSSPs with HFIP. A chimeric rSSP
that was soluble in Ni++ chromatography elution buffer (Tris-base, NaCl, Imidazole) was
able to be spun into fibers.14 The fibers produced from this chimeric sequence were
short in length and impractical to produce at a large scale. Also, a series of sequences
derived from aciniform silk (used for swathing and wrapping prey) that has roughly half
the Gly/Ala content of major ampullate silk26 were solvated with water and spun into
fibers. In this instance, the rSSP (76kDa) was solubilized in water and fibers were spun

9

from that solution. However, given the reduced Gly/Ala content and thus reduced βsheet content, the fibers were mechanically unremarkable.24
It is the principal goal of this dissertation to demonstrate a method that will
solubilize existing water insoluble rSSPs to produce rSSP fibers and other materials
using water and other green additives.
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CHAPTER 2
MECHANICAL AND PHYSICAL PROPERTIES OF RECOMBINANT SPIDER
SILK FILMS USING ORGANIC AND AQUEOUS SOLVENTS1

ABSTRACT: Spider silk has exceptional mechanical and biocompatibility properties. The goal of
this study was optimization of the mechanical properties of synthetic spider silk thin films made
from synthetic forms of MaSp1 and MaSp2, which compose the dragline silk of Nephila clavipes.
We increased the mechanical stress of MaSp1 and 2 films solubilized in both HFIP and water by
adding glutaraldehyde and then stretching them in an alcohol based stretch bath. This resulted
in stresses as high as 206 MPa and elongations up to 35%, which is 4 times higher than the as
poured controls. Films were analyzed using NMR, XRD, and Raman, which showed that the
secondary structure after solubilization and film formation in as-poured films is mainly a helical
conformation. After the post-pour stretch in a methanol/ water bath the MaSp proteins in both
the HFIP and water-based films formed aligned beta-sheets similar to those in spider silk fibers.

INTRODUCTION
Spider silk fibers have remarkable properties that could allow it to function in a
variety of applications including textiles, biomedical, and manufacturing applications.1–10
Of particular interest is dragline silk with both a high strength and elongation.1 In recent
years, producing spider silks synthetically has become a major point of emphasis
because spiders cannot be farmed as they are both territorial and cannibalistic. Efforts
1. Reprinted (adapted) with permission from (Tucker, C. L. et al. Mechanical and
Physical Properties of Recombinant Spider Silk Films Using Organic and Aqueous
Solvents. Biomacromolecules 15, 3158–3170 (2014).). Copyright (2014) American
Chemical Society.
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to produce recombinant spider silk proteins (rSSP) have focused on the production of
fibers2–4,11,12 while comparably little effort has been expended investigating alternative
forms such as films, hydrogels, lyogels, and adhesives.
Dragline silk is used as the lifeline for the spider and as structural support in the
web and is one of the strongest natural fibers known to man.1 Dragline silk is made up
of two different proteins: Major ampullate silk protein 1 (MaSp1) and Major ampullate
silk protein 2 (MaSp2), each with a molecular mass of around 300 kDa.13,14 Native
dragline silk is spun starting in the gland as a viscous water-based liquid crystal15,16 in a
micelle-like structure17 in a liquid dope. Beta-sheets are induced and aligned by the
friction of the duct as it decreases in diameter.18 Beta-sheets are also formed by the
removal of water from the liquid crystal15 or micelle-like structure.17
Nuclear magnetic resonance (NMR),5,19–26 Raman spectroscopy,27,28 and X-ray
diffraction (XRD),20,29–32 show that secondary structures in spider dragline silk are mainly
beta-turn, beta-sheet, and helical structures. Beta-sheets confer mechanical strength to
the silk and do not allow water penetration.26 Beta-sheets are mainly produced from the
alanine-rich regions, (An) and (GA)n in the protein. Type IIA turns are made from the
GPGXX (X is usually Y or Q) and GPGQQ repeat units, and glycine-II-helices are produced
from the GGX regions.6 These glycine-rich peptide regions allow penetration of water
and increase strain, which contributes to the overall toughness of the silk.33
Synthetic spider silk fibers have been spun using rSSp to mimic natural spider silk
properties.2–4,11,12 It has been shown that in order to produce a strong fiber the larger
the protein size the better the strength.4 The actual spinning process is also difficult to
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mimic, as current systems have a syringe and push the liquid dope out of small diameter
(0.005” to 0.01” ID) PEEK tubing,11 rather than the native pulling action. The secondary
structures in the fibers need to be induced and then aligned, done by using a
combination of a coagulation bath, liquid baths, and stretching.2–4,11 The fibers then
have to be woven or braided together to form a product.
Minimal research has been done on rSSp films. Recombinant spider silk film
formulations have recently been found to be a promising biological material for their
ability to attach and cause proliferation of fibroblast cells.7 It was also found that the
protein can be both genetically modified and chemically functionalized with cell
adhesive peptides.34 This allows for further applications in the medical industry.
Silkworm and spider silk films have also been studied for their biomedical applications
using fibroblasts, osteoblast-like cells, and skin cells7–10,35,36 all showing as much
attachment as traditionally used materials. The chemical stability of rSSp has also been
shown to be controllable using alcohol treatments37,38 and amino acid composition.39,40
The mechanical properties of spider silk films have been reported, but no reports have
improved on the initial properties.41,42 Of the studies done on silkworm silk films only
one was done to improve or to tailor the mechanical properties, which can make it a
candidate for a biological material and scaffolds for tissue engineering.43
An advantage of using films over fibers is that films do not need to be woven
together after processing to make functional products, which dramatically reduces the
cost of production. The production of a film can be as simple as formulating a dope and
pouring it. Dopes can also be modified by a change in formulation to have increased cell
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attachment,34,44 drug release,41 and mechanical properties.41,42 Film applications include
coatings for medical devices,45,46 skin grafts,10,43,47 drug delivery,41 and cellular
scaffolds.7,9,48 Improving and understanding the mechanical properties of films will
provide a base for further research that tailors films to specific applications.
rSSPs are conventionally dissolved in 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP)to create “dopes” that can be used to create fibers, films, gels, and foams, as well as
electrospun fibers and mats.49–52 HFIP has been widely used and accepted as a standard
solvent because it dissolves rSSPs at high concentrations (30% w/v), it is removed
rapidly from the forming silk fiber, and does not interfere with fiber formation. In
addition, rSSP’s are generally insoluble in aqueous solutions after purification.
There are significant problems with solvating rSSPs in HFIP or other organic
solvents at an industrial scale. HFIP is toxic to human health and to the environment and
has a high likelihood of having a cytological effect due to residual HFIP.52 HFIP is also not
cost effective nor is it simple to work with due to the need of a controlled environment.
To date however, there is no working process to efficiently dissolve rSSPs in any other
solvent that would be less toxic and costly. There have been investigators that have
used other solvents to produce fibers,2,15,16 but these have diminished mechanical
properties. The inability to solubilize rSSPs in aqueous solvents limits the applications of
synthetic spider silk.
This study presents a novel way of processing rSSp films with solubility in HFIP
and the introduction of an aqueous solvent to decrease environmental impact, cost of
processing, and toxicity. Even with the change of solvent, the mechanical properties of
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the films can be as high as, and in some cases, surpass those from films produced from
HFIP. Post-pour processing methods were utilized to improve secondary recruitment
and orientation, and thus properties.
The proteins in this study are rSSp’s produced in the milk of transgenic goats,
derived from the N. clavipes major ampullate silk proteins MaSp1 and MaSp2, which
combine to form the dragline fiber. The films are fabricated using a liquid dope, with
primarily HFIP or water used as a solvent, cast into a mold to produce films 10-30 µm
thick. The protein concentration and solvent composition are varied to increase
mechanical properties. Films are post-casting processed using a combination of vapor
treatments, liquid treatments, and stretching to increase stress, strain, and energy to
break. To our knowledge this is the first reported rSSp film production method tailoring
mechanical properties. Improving the mechanical properties of rSSP films will widen
potential applications for such materials.

MATERIALS AND METHODS
MaSp1 and MaSp2 Purification
Milk from transgenic goats is first collected and frozen, then 6-8 L of milk is
thawed, and defatted using a Milky cream separator (FJ60 by Clair®). The defatted milk
is brought to a pH of 9 using 0.1M arginine-HCl with the milk solution at 4˚ C for 30
minutes while stirring. The solution is then clarified and concentrated using tangential
flow filtration (TFF) with 750 kD and 50 kD membrane filters with the 750 KDa
permeate flowing into the 50 kD with the permeate flowing back into the 750 kD53. The
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retentate from each 750 kD column and 50 kD column are recycled through their
respective columns. The rSSP’s are precipitated from the 50 kD column retentate. Solid
ammonium sulfate is added slowly to a concentration of 1.2M while stirring to
precipitate the rSSP from the remaining milk proteins. The solution is allowed to
precipitate overnight and centrifuged at 15970g for 60 min. The supernatant is
removed and the pellet is washed multiple times using dH2O followed by centrifugation
at 15970g for 60 min until the conductivity of the supernatant is below 20 mS/cm. rSSP
pellets are then lyophilized to remove all water and tested for purity via Western blot
analysis using αM5 as a primary antibody and AP conjugated donkey anti-rabbit as a
secondary antibody (Santa Cruz Biotechnology).

PDMS Mold

Water
The mold is made from a PDMS (Dow Corning) solution of 5:1 base to initiator
and poured it into a 90 mm petri dish to approximately 1 mm thick. The petri dish and
solution is then placed into a vacuum chamber for 20 minutes to remove all bubbles.
They are then placed in an oven at 70 ºC to crosslink overnight. The solidified PDMS is
removed and cut using a forceps and a razorblade to four 30 x 7 mm strips (Figure 1),
with care taken to keep it clean of particulates. The mold is then thoroughly cleaned
using soap and water followed by isopropanol (IPA).
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Figure 1: PDMS strips with poured
spider silk dope over the top.

HFIP
The mold to form the films is made from a polydimethylsiloxane (PDMS) solution
of 20:1 base to initiator and pouring it into a medium sized petri dish to 0.2 mm thick.
The petri dish and solution is then put into a vacuum chamber for 20 minutes to remove
all bubbles. The solution is then set overnight in an oven at 70 ºC to harden. The
solidified PDMS is removed and cut using a forceps and a razorblade to four 30 x 7 mm
strips keeping the PDMS clean of particulates. The PDMS strips are placed in a new petri
dish side by side, avoiding touching, and a solution of 5:1 base to initiator PDMS solution
is poured over the strips, with the solution at least 1 mm above the strip. The petri dish
with the PDMS solution is placed into a vacuum chamber and the bubbles removed for
20 minutes, and then set overnight in an oven at 70 ºC to solidify. The PDMS is removed
from petri dish and the 20:1 strips are carefully removed using forceps and a razorblade
so as to not damage the 5:1 mold. The mold is then thoroughly cleaned using soap and
water followed by Isopropanol (IPA).
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Dope Preparation

Water
Standard water-based films are made using dopes which contain 4% MaSp1, 2%
MaSp2, and 3.5% 80/20 MaSp1/MaSp2 protein dissolved in water with additive.
Additives were included in the dopes to improve solubility, antibiotics and crosslinking.
These additives include formic acid (FA), acetic acid, arginine and glutamic acid, Urea,
ammonium hydroxide, kanamycin, glutaraldehyde (GTA), and imidazole using multiple
concentrations. The dopes are microwaved, using a 700W Magic Chef household
microwave, for a period of 30 seconds on full power in a sealed 3 mL Wheaton glass vial
to liquefy the dope and solubilize the protein. The dope is transferred into a
microcentrifuge tube and spun at 18000g for 1 min, the supernatant is transferred to
another microcentrifuge tube and the centrifugation repeated to remove any
particulate matter. All films are then immediately poured and spread onto four 30 x 7
mm polydimethylsiloxane (PDMS) strips with 200µL of dope on each strip.

HFIP
A standard dope contains 5% protein powder (w/v) dissolved in HFIP by
overnight rotary agitation and centrifuged for 2 min at 18000g to remove any
particulate matter remaining. The dope is carefully pipetted (200 µL) out of the vial and
poured into a pre-made PDMS mold described above, in a chemical hood (Thermo
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Scientific Hamilton Concept) with the sash opened as far as possible to slow air flow
over the films and decrease drying time.

Film Formation
The dope is carefully pipetted (200 µL) out of the microcentrifuge tube and
poured onto a pre-made PDMS well/strip (described above) in a Thermo Scientific
Hamilton Concept chemical hood with the sash opened to provide air flow over the films
and decrease drying time. After 1 day the water-based films (2 hours for HFIP-based
films) are dry, and starting to peel themselves off of the strips/wells. The films are
removed using forceps and the edges cut with a razor blade, producing a uniform flat
film.

Post-Pour Treatments

Vapor treatment
Films were first cut using a razor blade to 3.5 x 15 mm strips and weighed to
determine thickness (Equation 1). The cut films were then glued to a C-card
(Supplementary Information figure S1), as described below (mechanical testing section).
The films were vapor treated using different ratios of isopropanol (IPA), water, and
methanol (MeOH) at room temperature. Vapor treatment consists of putting the films
into a small petri dish, which is then nested into a larger petri dish with 5 mL of the
treatment solution in the bottom; the lid is placed on the larger petri dish to contain
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vapors. Cold treatment is simply putting the films into a closed petri dish and putting
them into a refrigerator. All treatments lasted for 30 minutes.

Stretching
To stretch the films a custom made stretching device (Figure 2) was created
using two, 3” x 3” x 1/4” inch (B and C) and two 3 1/8” x 3” x 1/2” (A and D) sheets of
polycarbonate secured by two 1/2” dowels 3/4” from the bottom and 1/2" from the
both sides and a 1/4 inch fiberglass dowel 1 3/4” from the bottom and in the center. All
dowels are glued to sheets A, C, and D. A 1/8 inch all thread rod is also placed through
all sheets except for the moving piece (B) which is threaded for piece B, A nut is also
added flush with part D on both sides in order to make part D move. An extra nut is also
placed at the extreme end at part E for ease of turning.
A

B

C

D

E

Figure 2: Diagram of the stretching apparatus
used to glue as-poured films (across B and C),
submerge the films in a stretch bath, and stretch
the films by turning the all thread (E) clockwise.

Untreated films (dried for a 24 h) were first cut using a flat edged razor blade on
a cutting board along the edges to ensure consistent thickness. The films are then cut in
half lengthwise and glued to the custom made stretching apparatus described above
(Figure 2). The stretching apparatus is inverted with the top of pieces B and C in a
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defined mixture of alcohol and/or water with percentages measured by volume, for a
period of 30 sec (2 minutes for water-based films). The apparatus is then rotated right
side up and the film strips immediately stretched by turning the all thread clockwise
(part E in Figure 2). With an initial film length of 8.5 mm the final length was determined
by multiplying the initial length by the stretch ratio, for example a 3X stretch has a final
length of 25.5 mm.

Mechanical Testing
The films, post-stretching, are cut to a specific length and width to weigh them
and calculate the thickness (Equation 1) using a density for dry spider silk fiber of 1.23
g/cm.3, 54–56 The films are then mounted on a plastic C-card (Figure S1) length wise using
Loctite super glue (liquid) across an 8 mm gap.57 After mounting, the C-card is loaded
on an MTS Synergie 100 (50N load cell) by clamping the top and bottom of the film and
card into the instrument with alligator clips and then cutting the side of the C-card
(indicated by the dotted line in Fig. S1) so the only thing being tested is the film.12 The
film is then tested to breaking at a stretch rate of 5 mm/min, with data collection at 30
Hz to measure the film’s load in order to calculate stress, strain and energy to break
using MTS’s TestWorks 4, 2001.
Thickness (cm) =

Weight(g)
g
1.23 ( 3 )(Width (cm)∗Length(cm))
cm

(1)
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Nuclear Magnetic Resonance (NMR)
All 13C solid-state NMR data were collected on a 400 MHz Varian Wide-Bore
instrument using a 1.6 mm solids triple resonance probe. Samples were packed into a
1.6 mm zirconia rotor and spun at the magic angle at 30 kHz MAS. 1H - 13C cross
polarization conditions were calibrated using 13C-enriched Glycine, and the CP condition
was met by using a ramped (~15%) 1H spin-lock pulse centered at 130 kHz RF field
strength, and a square spin-lock pulse on the 13C channel matched to the -1 spinning
side bands of the Hartmann Hahn profile. All spectrum were collected using a 50 kHz
spectral width, 8 ms acquisition time, 12288 scan averages, a 1 ms CP contact time, a 5
second relaxation time, and 150 kHz two-pulse-phase-modulated (TPPM) decoupling
was applied on the 1H channel during acquisition. 50 Hz exponential line broadening
was applied to each spectra prior to Fourier transform. The 13C chemical shifts are
referenced externally to TMS at 0 ppm by setting the downfield resonance of
adamantane to 38.56 ppm.

Raman
The films were analyzed using a home built Raman system. Films were placed
bridging the space between two parallel glass slides to eliminate background and
excited with a 150 mW 532 nm Coherent Sapphire SF laser focused onto the sample
with a 50x magnification APO plan Mitutoyo 2.0 cm working-distance objective. The
laser power was controlled using neutral density filters to make the power at the
sample 28 mW which optimized the balance between signal-to-noise and sample
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damage. The Raman signal was collected in back scattering geometry. The laser
wavelength was discriminated from the Raman signal using an Ondax SureBlock(TM)
ultra-narrow-band notch filter. An Acton Research SpectraPro 300i monochromator
with a 1200 g/mm grating coupled to a PI liquid nitrogen cooled CCD detector was used
to collect Raman signal for 5 acquisitions of 60 seconds each at a resolution of 1.5 cm1.

Cyclohexane and acetaminophen were used as calibrants.

X-Ray Diffraction
Samples were taken to the Advanced Photon Source located at Argonne National
Laboratory, Argonne IL, USA and wide-angle x-ray fiber diffraction was performed on
the BioCars 14BM-C beamline using a beam energy of 12.6 keV and approximate size of
130 x 340 μm. Films were mounted and were placed at a distance of 300mm from the
ADSC Quantum-315 9-panel CCD array detector. Stretched films were placed with the
stretched axis parallel to the beam stop and mounted to a goniometer. The exposure
time was 60 seconds for each of ten images averaged for each sample. For each sample,
5 background images were taken following each sample with the same parameters and
calibrated with CeO2. Images were then processed using Fit2D software and Matlab. The
water-based MaSp2 films were contaminated while at the synchrotron source and made
the x-ray diffraction data unusable.
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Field Emission Scanning Electron Microscopy (FE-SEM)
The films were imaged by field emission scanning electron microscopy (FE-SEM
Hitachi S-4000, Hitachi High-tech Corporation, Tokyo, Japan) to characterize their
morphology. The films were mounted on an aluminum stub and coated with a gold layer
10 nm thick.

Film Functionalization
HFIP dopes were made by dissolving 50 mg of MaSp1 powder in 1 mL of HFIP
and mixed overnight, 200 µL was poured into a PDMS mold (described in HFIP paper)
and allowed to dry. The kanamycin containing film was made by transferring 300 µL to a
new vial and adding 1 µL of kanamycin stock (15mg/mL), mixed for a minute using
rotary agitation, and then 200 µL was poured into a PDMS mold.
The water-based dope was made by microwaving 15 mg MaSp1 powder in 300
µL of water for 45 seconds and pouring 200 µL onto a PDMS strip as described above.
The kanamycin film was made the same way with the exception that the rSSP solution
was allowed to cool at room temperature to prevent degradation of the kanamycin. One
µL kanamycin (15mg/mL) was added to the dope for a final concentration of 50µg/mL.
The dope was mixed for a minute using rotary agitation before pouring 200 µL onto a
separate PDMS strip.
Two days after pouring the films, a lawn of E. coli XL1-Blue cells was established
on an LB agar plate and allowed to dry for 30 min in an incubator at 37 °C. Holes (6.5
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mm) were punched out of the films and a disc from each film was placed on the plate.
The plates were then placed in the incubator overnight to allow cell growth.

Statistical Analysis
All statistical analyses on tensile properties were done using a one-tailed t-test
assuming equal variance with a null hypothesis that the sample means are equal. A pvalue of < 0.05 is considered significant.

RESULTS
Preliminary Experimentation for HFIP-based Films
To create the films, a suitable substrate was investigated to create a mold for
film formation. Glass, aluminum, Teflon, and PDMS were all tested as substrates for film
formation and removal. The substrate that proved to be the best was PDMS due largely
to its hydrophobicity. The films could be peeled off easily after drying, which reduced
mechanical damage. PDMS also provides a smooth surface free of machine marks.
The next important step was to establish the best pouring and drying method.
An important factor in the pouring method was dope composition. It was found that 5%
protein dopes were easy to solubilize, pour, and provided a thickness of 20 - 30 µm. To
optimize the drying method, atomic force microscopy (AFM) was used to analyze
surface topography. In initial work during drying, pores were created throughout the
film. The pores are thought to occur due to the HFIP evaporating so quickly that it leaves
holes in the films as it bubbles out. Because of this, it was thought that a slower rate of
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evaporation would optimize film production. A variety of drying techniques were
investigated (Table 1) in order to achieve this. Pore tomography was measured using
atomic force microscopy (AFM) in tapping mode (Figure S2). The drying method that
was chosen to use throughout this study is drying in a chemical hood with the sash
opened as far as possible to slow the air movement. It was also assumed that because
the problem of pore formation arises from HFIP evaporation, this method could be
applied to all HFIP-based protein dopes.
Table 1. Comparison of pore sizes between pouring methods
measure by AFM
Pouring Methods
Pore
Pore
Pore Depth
Density
width
(nm)
(pores/µm) (nm)
MaSp2 Open sash
6.8
293
4.56
MaSp2 Refrigerated
7.4
625
>80
MaSp2 Turbulent Air
0.6
6200
230
MaSp2 Vacuum
11.4
449
5.15
Chamber
After optimizing the film production process, preliminary testing of un-processed
films using MaSp1, MaSp2, varying ratios of MaSp1 and 2, and different dope solvent
formulations including formic acid (FA) and glutaraldehyde (GTA) (Table 2) was
performed. Dopes with formic acid follow the procedure of a standard dope with the
exception that formic acid, 88%, is added to the dope before centrifugation and dopes
with GTA have the exception that after centrifugation the dope is removed carefully
from the vial and put into another vial and GTA (1 µL/mL) is added by pipette and the
vial gently rotated by hand before pouring.
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Table 2. Preliminary mechanical testing results with average deviations from untreated
MaSp1 and MaSp2 films with different dope formulations including no additives, GTA,
and 20% FA.
Average
Average Energy Average
Ultimate
Protein Solution
to Break
Ultimate
Strain
(MJ/m3)
Stress (MPa)
(mm/mm)
MaSp1
2.04 ± 0.81
42.12 ± 8.52 0.068 ± 0.02
MaSp1 w/ GTA
8.42 ± 9.67
32.97 ± 14
0.621 ± 0.77
MaSp1 w/ 20% FA
2.87 ± 1.09
50.4 ± 4.75
0.076 ± 0.03
MaSp2
0.64 ± 0.28
29.52 ± 2.49 0.036 ± 0.01
MaSp2 w/ 20% FA
0.66 ± 0.35
44.6 ± 6.34
0.028 ± 0.01
20/80 MaSp1/MaSp2 w/ 20% FA
1.3 ± 0.74
36.56 ± 11.09 0.051 ± 0.02
50/50 MaSp1/MaSp2 w/ 20% FA
0.47 ± 0.42
34.28 ± 12.1 0.024 ± 0.01
80/20 MaSp1/MaSp2 w/ 20% FA
3.73 ± 1.88
45.21 ± 12.65 0.13 ± 0.08
All untreated films mechanical properties were mechanically tested the same
day they were poured. Beta-sheet formation was measured on MaSp1 and MaSp2 films
with GTA using XRD over a week after pouring, which showed little difference between
the two (Figure 3A and S3). It is also evident through mechanical testing that formic acid
increases stress with the highest being MaSp1 with formic acid. The addition of GTA
increased strain, leading to a tripling of the energy to break for pre-processed films.
MaSp1 films with formic acid were also tested after conducting a vapor treatment,
which involved placing the films in a small petri dish, which was placed in a larger petri
dish with the treatment liquid and the lid placed over the large petri dish. The vapor
treatment time is 30 minutes and the films were tested for mechanical properties the
following day (Table S1). The IPA vapor treated films produced the highest average
stress 79.6, but the lowest average strain 0.03, suggesting an increase in beta-sheet
content.
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Preliminary Experimentation for Aqueous-based Films
With the discovery of PDMS as a suitable pouring substrate and the need for a
slow drying process, the development of aqueous film formation started with changing
the PDMS molds to a PDMS strip to overcome surface tension issues due to the use of
water. It was then necessary to establish a dope formulation.
The stability and processing of spider silk films depend on the composition of the
dope. Dope preparation began by using recombinant MaSp1, water, and formic acid
(0.1, 0.5, 1, 5, 10, 15, and 20 %), acetic acid (10, 15, and 20%), arginine and glutamic acid
(Arg Glu) (0.6, 12, 20, 30, 50, and 122 mM), Urea (4, 8, 160 mM), ammonium hydroxide
(50, 100, and 200 mM) or Imidazole (10 and 100 mM). MaSp2 films were also made
using formic acid (0.1, 2, 10, and 20%) and acetic acid (1, 5, 20%). All additives were
placed into the dope prior to microwaving.
Preliminary tensile testing was done on the films as-poured (no processing).
These films were screened for tensile strength, solubility, and processability. Solubility
was tested by placing the films into 5 mL of DI water. Processability was determined by
trying to stretch the films in different stretch baths, it was determined processable if the
film stretched without breaking to a minimum of 1.5X. Films from dopes containing urea
and ammonium hydroxide dissolved quickly in water (< 30 sec). Urea containing dope
films also dissolved in a mixture of alcohol and water, preventing further processing of
films (Table 3). The dope made with 0.1% formic acid proved to make films with a high
tensile strength and process ability than the other dopes.
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A

B

C

D

Figure 3: 2D WAXD images of MaSp1 spider silk
films as-poured (A) and post-pour stretched 2.5
times its original length following an 80/20
Methanol/Water bath (B). The double arrow in
(A) and (B) represents the direction of film stretch
alignment which is parallel to the beamstop
shadow (blue). Shown in (C) is the 1D azimuthal
intensity profile of radially integrated
reflections at 4.2 Å-1 of (B) with Gaussian fits. Full
1D radial intensity azimuthally integrated profile
of (D) with beamstop shadow and CCD detector
lines masked and fit to 5 Gaussian components.
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Tensile testing was done to understand variability between samples, structural
integrity and extension of the films (Table 3). It was previously hypothesized that high
extension (> 0.100) and low stress (≤ 50 MPa) led to a film that could be easily post-pour
stretched as indicated by the results from the HFIP-based film. This hypothesis was
Table 3: Comparison of mechanical properties and solubility of films made from
different dope formulations using MaSp1.
Energy to
Film
Concentratio
Additive
Break
Stress (MPa)
Strain (%)
Soluble
n
3
(MJ/m )
in water
Urea
4mM
0.42 ± 0.12
50.26 ± 8.62
1.7 ± 0.3
Y
8mM
0.43 ± 0.05
50.70 ± 3.04
1.7 ± 0.1
Y
160mM
0.44 ± 0.14
49.97 ± 7.74
1.6 ± 0.3
Y
Arginine
and
Glutamic
acid

0.6 mM
12 mM
20 mM
30 mM
50 mM
122 mM

0.64 ± 0.22
0.75 ± 0.25
1.96 ± 3.13
8.71 ± 8.74
7.47 ± 6.67
0.07 ± 0.02

61.82 ± 13.06
58.31 ± 7.94
50.32 ± 11.99
22.67 ± 2.62
15.64 ± 0.66
3.24 ± 0.9

2.0 ± 0.4
2.3 ± 0.6
4.5 ± 5.3
43. ± 39.7
51.2 ± 45.3
3.6 ± 0.5

N
N
N
N
N
N

Ammonium
Hydroxide

50 mM
100 mM
200 mM

0.41 ± 0.12
0.71 ± 0.24
0.68 ± 0.22

52.55 ± 6.86
62.83 ± 15.49
57.81 ± 11.98

1.7 ± 0.3
2.5 ± 0.6
2.4 ± 0.5

Y
Y
Y

Formic Acid

0.10%
0.50%
1%
5%
10%
15%
20%

0.61 ± 0.17
0.69 ± 0.19
0.84 ± 0.22
0.84 ± 0.4
0.64 ± 0.12
0.81 ± 0.04
0.87 ± 0.2

53.97 ± 4.73
58.15 ± 8.2
69.35 ± 7.28
65.24 ± 14.3
60.76 ± 7.52
71.36 ± 5.1
66.56 ± 7.4

2.5 ± 0.4
2.5 ± 0.2
2.6 ± 0.4
2.5 ± 0.7
2.4 ± 0.3
2.5 ± 0.2
2.7 ± 0.4

N
N
N
N
N
N
N

Acetic Acid

10%
15%
20%

2.63 ± 1.18
0.94 ± 0.22
24.28 ± 9.43

50.56 ± 5.63
50.35 ± 9.17
36.58 ± 2.24

6.9 ± 3.0
3.4 ± 1.0
82.6 ± 29.6

N
N
N
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disproved as dope formulations making as-poured films with a high degree of
extensibility (20% acetic acid and 30mM arginine and glutamic acid) could not be further
processed. Dopes containing propionic acid (0.1 and 10%) and imidazole (10 and
100mM) were also made. Preliminary mechanical testing was not done on these films as
they also broke when force was applied in the stretch bath. Films with 0.1% formic acid
permitted alcohol and water treatments, as well as stretching, both of which increased
mechanical properties. Due to the ease of processability, the dope formulation
containing 0.1% formic acid was used for the remainder of the experiments.
Additionally, 0.05% GTA was also used due to the positive results from HFIP-based films,
showing that it increases both stress and strain. A similar problem was encountered
when MaSp2 films were stretched using any variety of alcohol and water
concentrations, breaking the films instead of actually stretching them. To solve this
problem MaSp1 was mixed in with MaSp2 at different concentrations until the films
were able to be processed, arriving at 80% MaSp1 and 20% MaSp2 based on weight.
Films that were made with 0.1% formic acid and 0.05% GTA were then
characterized using XRD, showing that the MaSp2 films have more crystallinity than the
MaSp 1 films (Figure 4 and S4). Since the pure MaSp2 films could not be post-pour
stretched, it is hypothesized that the high beta-sheet content prevents the penetration
of water. MaSp2 dopes also gelled faster than MaSp1 dopes after microwaving, due to
the higher beta-sheet content, making it difficult to remove particulates and pour.
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Figure 4: XRD images of as-poured spider silk films
MaSp1 (A), post-pour stretched 2.5 times its
original length after an 80/20 Methanol/Water
bath (B), 1D radial integration profile of the whole
2D pattern of B (C), and the 1D azimuthal intensity
profile of B (D). The double arrow in A and B
represents the direction of film stretch alignment
which is parallel to the beamstop shadow (blue).
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Stretching Films
Stretching spider silk fibers has been shown to increase both stress and strain 2–
4,11

by aligning secondary structure. In this study a similar technique is used to improve

mechanical properties. Initially, the films were stretched by hand, but this method of
stretching was both difficult and unreliable. A stretching apparatus custom made in our
laboratory (Figure 2) was created to establish an easy method to create a consistent,
uniform stretch. This apparatus made it possible to obtain results that were
reproducible and also made it possible to stretch multiple films simultaneously. It is
important to note that with HFIP-based films, formic acid impaired the post-pour
stretching of the spider silk films after the stretch bath and therefore was not included
in the dopes for stretched films. It is hypothesized that formic acid increases beta-sheet
content preventing sufficient penetration of water or alcohols.

Post-pour Processing of HFIP-based Films
The best stretching results were established by using a 2-3X stretch and testing
different ratios of IPA, methanol (MeOH), and water in the bath. The results of these
experiments (Table 4 and Figure 5) show that the films stretched in the 80/20
MeOH/water bath performed the best with an average energy to break more than twice
that of the other films.
To examine the stretch factor on films, the 80/20 MeOH/water solution was
used to determine mechanical changes in a range of stretching ratios (Figure 6). As the
stretch factor increased, stress increased up to a maximum of 210 MPa, while strain

35

Table 4. Mechanical properties of films with average deviations after post-pour stretch using set
ratios of IPA, MeOH, and water
Average
Average Energy
Average
Dope Composition + Stretch Solutions with
Ultimate
to Break
Ultimate
Stretch Ratio
Strain
(MJ/m3)
Stress (MPa)
(mm/mm)
MaSp1 with GTA + MeOH 2 X
18.65 ± 8.95
109.61 ± 8.69 0.204 ± 0.1
102.91 ±
MaSp1 with GTA + 50/50 IPA/water 3 X
23.14 ± 5.7
0.258 ± 0.06
12.44
112.69 ±
MaSp1 with GTA + 80/20 MeOH/water 2 X
25.8 ± 9.61
0.257 ± 0.08
15.03
MaSp1 with GTA + 80/20 MeOH/water 2.75
189.39 ±
42.1 ± 9.76
0.281 ± 0.05
X
17.25
MaSp1 + 50/50 MeOH/IPA 2 X
23.58 ± 12.31
75.59 ± 17.66 0.334 ± 0.12
MaSp1 + 80/20 MeOH/water 2X
14.19 ± 8.57
117.4 ± 14.08 0.137 ± 0.06

Figure 5: Bar graphs for stretched films showing average stress, strain, and energy to break
with x being the median and the dashes representing minimum and maximum.
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decreased by at least 25% with each incremental step. With an increased stretch factor
the stress-strain graph changes, the yield strength increases, and the slope following
that point increases. The films with 2.5 X stretch show a yield behavior with slight strain
hardening, and the films with 2.75 and 3.25X stretch factor show strain hardening and
no yielding directly after the initial jump in stress. This shows that the films can be
tailored to different applications, with only a change in stretch factor.
80/20 Methanol/Water Increasing Stretch

Stress (MPa)

200
150
100
50
0
0

0.1

0.2

0.3

0.4

0.5

Strain

Figure 6: Select stress-strain graphs of MaSp1
samples with GTA films to illustrate the difference
in stress and strain with a given stretch factor
using 80/20 MeOH/Water as a stretch bath. With
the following legend: 2.5X stretch (solid line),
2.75X stretch (dotted line), and 3.25X stretch
(dashed line).

Previous research on mechanical properties of gelatin films has revealed that
GTA can increase crosslinking of protein, which increases mechanical properties,
primarily stress.58,59 Preliminary testing showed that the spider silk films with GTA had
higher strain but lower stress (Table 2). After this discovery, GTA was used in the dope
for all post-pour stretched films. This produced an increase in both stress and strain and
also increased consistency (Table 4). Testing showed that the GTA only helps after the
films dry for a full day prior to post-pour treatment.
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After establishing processing procedures, MaSp2 dopes were also made, as well
as MaSp2/MaSp1 combination dopes. The resulting films were processed using 80/20
MeOH/Water and 2.5X stretch with GTA in the dope (Figure 7). There was no significant
difference in stress or strain between the films that contained mixed proteins, with an
average ultimate stress at 139 MPa and ultimate strain at 29.7%. The MaSp1 protein
films had the highest stress (182 MPa) and the MaSp2 protein films the highest strain
(33%).
MaSp1 vs MaSp2 Comparisons

Stress (MPa)

200
150
100
50
0
0

0.1

0.2
Strain

0.3

0.4

Figure 7: Stress-strain graphs comparing films
composed of MaSp1, MaSp2, or a mixture of
MaSp1/MaSp2; all samples received the same
post-pour treatment. With the following legend:
MaSp1 (dashed line), 75/25 MaSp1/MaSp2 (solid
line), 50/50 MaSp1/MaSp2 (single dotted dashed
line), 25/75 MaSp1/MaSp2 (dashed line) and
MaSp2 (double dotted dashed line).

Post-pour Processing of Aqueous-based Films
With established procedures for post-pour stretching of HFIP-based films, the
water-based films were then stretched to increase mechanical properties. The primary
difference in making the change to water-based films was that they needed to soak in
the stretch bath for 2 minutes instead of 30 seconds for the HFIP-based films.
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Following the preliminary testing of the dope compositions, films (both MaSp1
and 80/20 MaSp1/MaSp2) with 0.1% formic acid and 0.05% GTA were stretched in a
combination of water and alcohol resulting in the highest energy to break (62 MJ/m 3)
for recombinant silk protein films (Table 5 and Figure 8). The results of mechanical
testing also demonstrate that 80/20 (w/w) MaSp1/MaSp2 films treated in 80/20 (v/v)
MeOH/water yield the highest stress with a lower stretch ratio. Using this treatment,
films cannot be stretched past 2.7 X without breaking. Treating 80/20 (w/w)
MaSp1/MaSp2 films in 50/50 (v/v) IPA/water increases the energy to break with a 39%
strain and moderate (177 MPa) stress. With a higher stretch ratio and using the
described treatment, films can be post-pour stretched up to 3.2 X their original length,
although stretching past 3 X results in reduced strain.
Table 5: Mechanical properties of films with average deviations after post-pour stretch using set
ratios of IPA, MeOH, and water

Material + Stretch Solutions with Stretch Ratio

MaSp1 + 50/50 IPA/Water 2.5X
MaSp1 + 80/20 MeOH/Water 2.5X
80/20 MaSp1/MaSp2 + 80/20 MeOH/Water 2.5X
80/20 MaSp1/MaSp2 + 80/20 MeOH/Water 2.7X
80/20 MaSp1/MaSp2 + 50/50 IPA/Water 3X
80/20 MaSp1/MaSp2 + 50/50 IPA/Water 3.2X

Average
Energy to
Break
(MJ/m3)
30.44 ± 3.55
40.6 ± 3.34
40.58 ± 10.9
47.06 ± 3.08
52.36 ± 8.02
34.58 ± 10.7

Average
Ultimate Stress
(MPa)
136.66 ± 2.06
149.42 ± 7.27
168.35 ± 20.76
206.81 ± 3
183.92 ± 14.85
177.56 ± 3.57

Average
Ultimate
Strain
(mm/mm)
0.253 ± 0.02
0.335 ± 0.02
0.307 ± 0.1
0.289 ± 0.02
0.354 ± 0.07
0.239 ± 0.07
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Figure 8: Histogram of the mechanical properties for stretched films showing average stress, strain, and
energy to break where bar height represents the average value, and x the median with dashes
representing maximum and minimum values.

The surface of the MaSp1 films were imaged using a scanning electron
microscope (SEM), showing that the film after stretching remains smooth (Figure 9). It
also shows that the cut edge of the film may be porous or damaged due to cutting. This
is not a desirable feature, but the films need to be cut to remove the thick edges. Using
these SEM images we also verified that the thickness measurements are accurate and
reliable (Figure 9).
A

B

Figure 9: SEM image of the surface (A) and cut
edge (B) of stretched MaSp1 films after 80/20
MeOH/water 2.5X stretch. Arrow indicates stretch
direction. Scale bars: A. 30 µm, B. 12 µm.
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Characterization of HFIP-based Films
MaSp1 and MaSp2 films processed using 80/20 MeOH/water stretch bath, and
stretched to 2.5 X, were also characterized using XRD, the images show an increase in
beta-sheet content and alignment (Figure 3B and S3B) from the films that were not
stretched (Figure 3A and S3A). Wide-angle X-ray diffraction of the films yields nanocrystalline Bragg reflections and an amorphous halo. The XRD pattern shows that the
crystalline structure within the stretched films is also aligned parallel to the stretch
direction, with calculated Herman's orientation factors, fc, of 0.858 for MaSp1 and 0.838
for MaSp2, determined from azimuthal broadening of the equatorial reflections where
𝑓𝑐 is calculated (equation 2) from the angle, φ, between the longest axis and the fiber
axis.
𝑓𝑐 =

3𝑐𝑜𝑠2 𝜑−1
2

(2)

Radial integration along the equator gives the peak positions and widths of the
(200) and (120) reflections which are used to calculate the a and b axes of the unit cell
and nanocrystal dimensions. Along the meridian, the (002) reflection gives the
information concerning of the c-axis of the unit cell. Spider silk proteins have been
shown to form orthorhombic unit cells and the unit cell dimensions calculated from the
peak positions of wide angle X-ray diffraction WAXD reflections are calculated from
equation 3 where d is the peak position in d spacing and hkl are the Miller index
notation:60
1
𝑑2

ℎ2

𝑘2

𝑙2

= 𝑎2 + 𝑏2 + 𝑐 2 (3)
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Radial integration along the equator (Figure 3C) and meridian were fit to
Gaussian peaks and the peak positions were converted to inverse space following
Bragg’s Law to calculate unit cell dimensions. Average crystallite size in each dimension
is calculated from the radial broadening in 2θ space using Scherrer’s formula and these
results are shown in Table 6.61
Table 6: Unit cell and crystallite dimensions calculated from
WAXD.
Material
Unit cell (Å)
Crystallite (nm)
MaSp1 post-stretch
film
MaSp2 post-stretch
film

6.90 x 9.73 x 10.50

0.80 x 3.18 x 9.99

6.75 x 9.87 x 10.03

0.74 x 3.11 x 24.7

The crystallinity, xc, can be estimated by radial integration of the equatorial
reflections (Equation 4) which are the crystalline peaks due to Bragg diffraction relative
to the full integrated peak area yielding 47.3% and 48.2% crystallinity for MaSp1 and
MaSp2, respectively.62
𝑥𝑐 =
13C

𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑 𝑒𝑞𝑢𝑎𝑡𝑜𝑟𝑖𝑎𝑙 𝑟𝑒𝑓𝑙𝑒𝑐𝑡𝑖𝑜𝑛𝑠
𝐹𝑢𝑙𝑙 𝑟𝑎𝑑𝑖𝑎𝑙 𝑖𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑖𝑜𝑛

(4)

solid-state NMR data collected on MaSp1 and MaSp2 films is presented in

Figure 10 and the information is used to track molecular-level structural changes during
the course of film production. Chemical shifts for relevant amino acids alanine, glycine,
serine, proline and glutamine are indicated with dotted lines, and red arrows are used
to emphasize changes to silk secondary structure during film production. For both
MaSp1 and MaSp2 samples, the film progress is tracked from top to bottom; purified
protein powder (10A, 10D) is solubilized in HFIP and casted as a film in PDMS wells (10B,
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10E). As-poured films were then stretched 2.5X in a bath of 80/20 MeOH/water (10C,
10F). In both cases initially, the alanine-rich regions within the purified MaSp1 or
MaSp2 protein powders exist primarily in a beta-sheet conformation. This is expected;
the purified protein is not water soluble, presumably because of the polyalanine betasheet aggregates. HFIP is commonly used to solubilize large silk-like proteins because of
its ability to disrupt insoluble beta-sheets and stabilize alpha-helical secondary
structures.63,64 Our NMR data indeed shows a dramatic transformation of polyalanine
regions into an alpha-helical conformation for films cast from HFIP silk dopes. This is
evident in the characteristic downfield and upfield shifts of Ala Cα and Ala Cβ
resonances, respectively, as illustrated by the outward pointing red arrows. While the
majority of volatile HFIP solvent is removed via evaporation, the 13C resonance near 70
ppm is attributed to residual HFIP that remains bound to the silk protein backbone.
NMR data shows a transformation of polyalanine regions from helical back to betasheet structures when as-poured films are stretched in 80/20 MeOH/water; again this is
highlighted by inward-pointing red arrows. In the case of the MaSp2 sample where
serine, which is often contiguous to the polyalanine regions, is well represented, we
notice a similar trend. HFIP solubilization encourages a helical structure, but a significant
fraction of serine residues are driven into a beta-sheet conformation upon stretching.
This structural transformation is also correlated with the loss of the HFIP resonance near
70 ppm, indicating that the helical-stabilizing organic solvent is driven away from the silk
protein during the stretching procedure. NMR data therefore strongly suggests that
alanine-rich repeat motifs from both MaSp1 and MaSp2 films form beta-sheet
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nanocrystalline structures. This is in line with WAXD results that indicate both betasheet formation and axial alignment upon stretching the films in alcohol/water baths.

Figure 10: 1H - 13C CP-MAS spectra of MaSp1 films (left) and MaSp2 films (right) in various stages
of production. Some resonances from dominant amino acids glycine, alanine, serine, proline and
glutamine are highlighted with dotted lines, and protein secondary structure is indicated when
appropriate. Red arrows are used to emphasize structural changes occurring during production.
From top to bottom: Purified protein powder (A, D), as-poured films from solubilized protein in
HFIP (B, E), and films stretched in 80/20 MeOH/water (C, F).

Multidimensional NMR would be necessary to extract precise chemical shifts for
proline and glutamine residues, thus a complete characterization of GPGXX motifs in
MaSp2 films is not possible. However, the collective chemical shifts of Pro Cγ / Glu Cβ
and Pro Cβ / Glu Cγ at 25 and 30 ppm, respectively, are very consistent with natural
dragline spider silk samples. NMR experiments on the MaSp2-rich Argiope aurantia
spider dragline silk found that GPGXX motifs from MaSp2 protein exist in elastin-like
type II beta-turn structures.23 It is therefore likely that MaSp2 films share this structure.
The resonance at 25 ppm from GPGXX regions also shows a narrowed line shape in
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stretched MaSp2 films as compared to the protein powder and the as-poured film. This
observation suggests that stretched films contain a more uniform distribution of
chemical shift and therefore less heterogeneity in the distribution of molecular
environments. This is consistent with XRD data that show an increase in molecular
orientation upon stretching. It is concluded that the act of film stretching in
alcohol/water baths not only drives out HFIP and induces beta-sheet formation of
alanine-rich regions, but also improves alignment and regularity of both beta-sheet
nanocrystals and elastin-like GPGXX structures.
Raman spectroscopy characterization was also done on the spider silk powder,
untreated films and post-pour stretched films (Figure 11). This illustrates the secondary
structure changes taking place as the MaSp1 and MaSp2 films are being processed. The
powder consists primarily of beta-sheet and little helical conformation (11A, 11D). After
solubilizing and pouring, the film switches to a helical conformation with little betasheet content (11B, 11E). After the stretch bath and subsequent stretching the film
reverts back to a beta-sheet conformation bringing it full circle (11C, 11F). This increased
beta-sheet content along with the alignment that occurs with stretching increases the
energy to break over 20 times from the unprocessed films. Previous studies have shown
β-sheet contributions at 1670 cm-1 and helical peaks at 1656 cm-1 and assigned
unordered peaks near 1640 cm-1. Figure 11B and 11E both appear to show an increased
peak amplitude near 1656 cm-1 which further confirms the conversion of β-sheet
secondary structure to helical and back.27
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Figure 11: Raman spectra of the progression of
MaSp1 films (top) and MaSp2 films (bottom) in the
amide III and amide I regions. Red arrows are used
to emphasize structural changes occurring during
production. From top to bottom: Purified protein
powder (A, D), as-poured films from solubilized
protein in HFIP (B, E), and films stretched in 80/20
MeOH/water (C, F).

Characterization of Aqueous-based Films
Wide-angle X-ray diffraction of the films yields nano-crystalline Bragg reflections
and an amorphous halo. The XRD pattern shows that the crystalline structure within the
stretched films is also aligned parallel to the stretch direction, with a calculated
Herman's orientation factor, fc, of 0.823 for MaSp1, determined from azimuthal
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broadening of the equatorial reflections where 𝑓𝑐 is calculated (as previously explained)
from the angle, φ, between the longest axis and the fiber axis (Figure 4).
The a and b axes of the unit cell and nanocrystal dimensions were calculated as
described previously. Radial integration along the equator (Figure 4C) and meridian
were fit to Gaussian peaks and the peak positions were converted to inverse space
following Bragg’s Law to calculate unit cell dimensions. Average crystallite size in each
dimension is calculated as outlined previously, results are shown in Table 7 61

Table 7: Unit cell and crystallite dimensions calculated from
WAXD.
Material
Unit cell (Å)
Crystallite (nm)
MaSp1 post-stretch
film

6.92 x 8.86 x 11.37

1.93 x 3.34 x 7.86

The crystallinity, xc, can be estimated by radial integration of the equatorial
reflections which are the crystalline peaks due to Bragg diffraction relative to the full
integrated peak area as shown previously, yielding 48.8% crystallinity for MaSp1.62
The molecular protein structure of the films also was tracked through
successive stages of film production using 1H – 13C CP-magic angle spinning (MAS) NMR
(Figure 12). 13C chemical shifts are very sensitive to protein secondary structure, and can
therefore be utilized to monitor structural changes throughout film production.
Chemical shifts that arise from alanine Cα and Cβ in either a beta-sheet or
helical/random coil conformation are indicated with dotted lines in Figure 12. The films
are essentially produced from powder to final product; initial MaSp1 protein powder
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(12A) is solubilized into an aqueous-based silk dope, which is cast as an as-poured film
(12B). The poured films are then submerged in a bath of 80/20 MeOH/water and
stretched 2.5X (12C). The data shows that the purified MaSp1 protein powder (12A) is
dominated by alanine in a beta-sheet conformation. When the silk protein is solubilized
and cast into films, the data reveals that alanine originally in a beta-sheet conformation
is partially converted to helical or random-coil structures. Similar to HFIP solubilization,
it appears that dissolution of silk protein in an aqueous medium is correlated with a
decrease in alanine adopting a beta-sheet structure (12B). However, the more stable
beta-sheet structure is recovered when the as-poured films are stretched in 80/20
MeOH/water (12C). These results are consistent with trends observed for HFIP-based
films with the exception that there is no HFIP peak in aqueous films. This would lead us
to believe that we are essentially creating the same films using a water-based dope vs.
HFIP, lowering the cost of materials, improving biocompatibility and improving the
environmentally friendly aspect of this biomaterial.
Raman spectroscopy characterization was also done on the spider silk powder,
untreated films and post stretch films (Figure 13). These results confirm the previous
findings of NMR that the powder consists primarily of beta-sheet and little helical
conformation, after solubilization and pouring, the film converts to a helical
conformation with little beta-sheet content, and after stretch bath and subsequent
stretching the film reverts back to beta-sheet content. These results are also similar to
those found previously.
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Figure 12: 1H-13C CP-MAS spectra of MaSp1 films in various stages of production.
Resonances for alanine and glycine residues are highlighted with dotted lines, and protein
secondary structure is indicated when appropriate. The data suggests that the MaSp1
starting material (A) originally contains a significant β-sheet component. The protein is then
solubilized in an aqueous-based silk dope, where the β-sheet fraction is expected to have
decreased during solubilization. Films poured from this dope indeed show a decrease in βsheet content (B). β-sheet content is clearly recovered upon stretching of the as-poured
films in 80/20 MeOH/H2O (C).
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Figure 13: Raman spectra of the progression of
MaSp1 films in the amide III and amide I regions.
From top to bottom: Purified protein powder
(1), as-poured films from solubilized protein (2),
and films stretched in 80/20 MeOH/water (3).

Functionalization of Films
As proof of concept, to show the potential for these spider silk films in medical
applications, two water-based films and two HFIP films were produced, the first of the
two contain kanamycin in the dope and the second contain no additives. The films were
placed on an agar plate that had been seeded with XL-1 Blue cells (Figure 14). Both HFIPand water-based films containing kanamycin generated a zone of inhibition on the
bacterial lawn. Water-based films without kanamycin produced no zone of inhibition;
however the HFIP-based film without kanamycin produced a narrow zone of inhibition,
demonstrating that there is a cytological effect (residual HFIP) (Figure 14) preventing
growth of cells.65
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A

B

C

D

Figure 14: Zone of inhibition of films with and
without kanamycin. HFIP-based film with
kanamycin (A), HFIP-based film (B), water-based
film with kanamycin (C), and water-based film (D).

DISCUSSION
These results show that rSSp films can be formed after dissolving them in a
water or HFIP solution. The mechanical properties of as-poured films from both are
similar, with the addition of formic acid increasing stress. It is clear that post-pour
processing of films greatly increases the mechanical properties; these mechanical
properties can be tuned to each application using a combination of dope formulation,
stretch baths, and stretch ratios. The addition of GTA to the dope before pouring also
increases strain in films processed in 80/20 MeOH/Water without a significant change in
secondary structure suggesting that GTA may induce crosslinking between proteins.
Changing the processing conditions, such as stretch baths and stretch ratios, changes
the conformation of the silk protein, making the secondary structure tunable for
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commercial applications. The rSSp powder is initially in a beta-sheet conformation, after
dissolving in HFIP or water and pouring the protein takes a mainly random alpha-helical
conformation, after post-pour stretching the protein reverts to a beta-sheet rich
conformation aligned in the stretch direction which has been confirmed by a
combination of WAXD, Raman, and NMR.

Table 8: Comparison of the mechanical properties of silk, collagen, and other
materials43.
Ultimate
Ultimate
Material
Form
References
Stress (MPA)
Strain (%)
Spider silk
1
fiber
4000
35
(dragline)
HFIP-based
Recombinant
film
189
28
This study
spider silk
Water-based
Recombinant
film
206
29
This study
spider silk
Other
41
Recombinant
film
54
1.8
spider silk
Ultrathin
43
B. mori silk fibroin
100
0.5-3.0
films
59
Collagen X-linked
film
47–72
12–16
Polylactic acid
43,66
sheet
28–50
2–6
(PLA)
66

PMMA

plate

55–76

2–5

The results of these experiments also are the highest published stress and strain
of any recombinant spider or silkworm silk films (Table 8), making it a strong candidate
for use in a variety of products. Spider silk is a biocompatible67 and biodegradable41
material suitable for use in multifunctional biomaterials. The comparison of MaSp1 and
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2 films also shows that with despite similar alignment and processing, the MaSp2 films
do not perform as well as MaSp1 films.
The use of water instead of HFIP in the dope construct for film formation has the
potential to change the processing of spider silk products due to its low cost of
production and significant lowering of toxicity to the environment and people. We have
been able to produce a water-based film that is similar in structure and mechanical
abilities to HFIP based films, which makes the water based films even more valuable.
Thus, aqueous derived rSSP films reduce the cost of production, the toxic impact
on the environment and improves biocompatibility over similar HFIP derived films. Due
to the aqueous nature of the dopes, further functionalization may be more possible
with aqueous films than with HFIP or other organic solvent derived rSSP materials. HFIP
solvates rSSP by converting the tight beta-sheet structures to helical or random coil
structures, negating the possibility of functionalizing the rSSP with protein therapeutics
as they could also be denatured.

CONCLUSION
It has been shown that films produced from an aqueous dope have similar
structure to those created by an HFIP dope, producing essentially the same film with a
lower cost and impact on the environment. Maximum stress values of over 200 MPa
were observed in processed films with a maximum energy to break over 60 MJ/m 3, and
maximum strain over 40%. These values are the highest mechanical properties reported
on materials used as a scaffold for cell growth (Table 8), with a stress at least double
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that of all others. As well, films generated from rSSP solvated in water matched or out
performed those same proteins when solvated with HFIP.

SUPPORTING INFORMATION
AFM images of MaSp2 films comparing drying methods, mechanical properties
of vapor treated films, and XRD images of as-poured (water and HFIP-based) and
stretched MaSp2 films (Only HFIP-based). This material is available free of charge via the
Internet at http://pubs.acs.org.
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CHAPTER 3

MORE THAN JUST FIBERS: AN AQUEOUS METHOD FOR THE PRODUCTION OF
INNOVATIVE RECOMBINANT SPIDER SILK PROTEIN1

ABSTRACT: Spider silk is a striking and robust natural material that has an unrivaled
combination of strength and elasticity. There are two major problems in creating
materials from recombinant spider silk proteins (rSSps): expressing sufficient quantities
of the large, highly repetitive proteins and solvating the naturally self-assembling
proteins once produced. To address the second problem we have developed a method
to rapidly dissolve rSSps in water in lieu of traditional organic solvents, and accomplish
nearly 100% solvation and recovery of the protein. Our method involves generating
pressure and temperature in a sealed vial by using short, repetitive bursts from a
conventional microwave. The method is scalable and has been successful with all rSSps
used to date. From these easily generated aqueous solutions of rSSps a wide variety of
materials has been produced. Production of fibers, films, hydrogels, lyogels, sponges,
and adhesives and studies of their mechanical and structural properties are reported. To
our knowledge, ours is the only method that is cost effective and scalable for mass
production. This solvation method allows a choice of the physical form of product to
take advantage of spider silks’ mechanical properties without using costly and
problematic organic solvents.
1) Reprinted (adapted) with permission from (Jones, J. A. et al. More Than Just Fibers: An
Aqueous Method for the Production of Innovative Recombinant Spider Silk Protein
Materials. Biomacromolecules (2015). doi:10.1021/acs.biomac.5b00226) Copyright
(2015) American Chemical Society
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INTRODUCTION
A spider spins fibers from an aqueous solution.1–3 The fibers, comprised nearly
entirely of protein, have long been studied and admired for their combination of
tenacity, elasticity and strength.3–6 Given that spiders cannot be farmed for their silk
due to their territorial and cannibalistic nature, substantial effort has been made to
generate proteins synthetically. While generation of recombinant spider silk proteins
(rSSps) has been successful in a variety of hosts, the vast majority of rSSps are sparingly
soluble in water when produced.7, 8 A spider’s web does not dissolve in high humidity or
rain, which lends some insight as to why these rSSps are so difficult to solubilize in an
aqueous based solution. Highly aligned and ordered structures are present in the fibers
that prevent them from dissolving and these structures are present to some degree in
the rSSps when purified from their host organism.9–12
Spiders use complex biological and chemical mechanisms to produce their large
(>250 kDa) spider silk proteins and maintain them in a liquid crystalline state within the
gland.13,14 The native N- and C-termini of the proteins have been shown to aid in the
aqueous solubility of the proteins when produced by the spider.15 The natural tendency
is to include one or both of those sequences in the rSSps produced. However, inclusion
of these sequences does not make the rSSps immediately water soluble. Rather,
multiple steps for solubilization must be taken to first dissolve the protein in a
chaotropic agent and then slowly remove it through dialysis.8,16
While dialysis based methods do work to generate largely aqueous soluble rSSps,
it does not work in all cases (Lewis, unreported recombinant major ampullate Spidroin 1
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(rMaSp1) and 2 (rMaSp2)) nor is it tenable at large-scale to produce commercially
available products from rSSps. Dialysis bags and the like are functional at the laboratory
scale due to their low volumes.17–19 However, at production scales the processes for
buffer removal induce major agitation in systems such as tangential flow filtration.
Recombinant spider silk proteins are known to become viscous or precipitate, due to
self-assembly as a result of increased shear which occurs naturally in the spider. As a
result, buffer exchange is unlikely to work at large-scale as not all rSSps are soluble in
guanidine or similar chaotropes and the loss of protein from multiple manipulations or
precipitation during buffer exchange and centrifugation can be substantial.20,21
In absence of a viable large-scale method, there is a distinct need for solvating
rSSps in aqueous based solutions. We report here a method for taking traditionally
water insoluble rSSps and solvating them in a quick, one step process with nearly 100%
solvation and recovery in water without degrading the protein (Figure S1). From these
solutions fibers, films, gels, sponges, adhesives, foams, and coatings have been
produced (Figure 1) and analyzed as reported below. These diverse materials have been
studied for their mechanical abilities, ability to be functionalized and in appropriate
cases, their protein structure.

MATERIALS AND METHODS
Protein Purification
As previously reported rMaSp1 and rMaSp2 proteins were purified from the
milk of transgenic goats through tangential flow filtration, precipitation, and washing. 25
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Solubilization
A specific dope formulation and volume was placed in a glass vial (Wheaton),
the mixture was sonicated at a power setting of 3 W for one minute. This suspension
was then sealed and heated in a 700 W Magic Chef® microwave oven in 5-second
intervals. This process was repeated until the protein was completely solubilized and
the cap temperature was greater than or equal to 130 °C, which was determined using a
Fluke 561 handheld infrared thermometer.

Fiber Formation
Solutions of 12% (w/v) 50/50, 80/20, and 90/10 rMaSp1/rMaSp2, respectively,
with 90/10 containing 0.1% propionic acid, 10mM imidazole were solubilized. After
solubilization, the solution was removed and centrifuged at 18,000 rcf for 3-minutes.
The supernatant was then removed and loaded into a 3 mL glass syringe with a luer-lock
(Grainger). Two needles (0.178 mm internal diameter made from PEEK tubing) are
attached to the syringe through a luer-lock. The syringe and needle configuration is
then loaded into a custom wet spinning extrusion device. The apparatus has
controllable three godet systems that are controlled independently allowing for two
separate stretches to be applied to the fiber and a fiber accumulating winder. The
spinning apparatus is equipped with three baths. The first bath (bath) is filled with
100% isopropanol (IPA), the second bath (1st stretch) contains an 80/20 mixture of
IPA/water and the third bath (2nd stretch) contains a 20/80 mixture of IPA/water. The
fiber is formed by extruding the protein solution into the coagulation bath (IPA) at a
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controlled rate. The fibers were pulled from the coagulation bath and strung through
the godets, submerged in the two stretch baths, then onto the winder. Varied stretch
ratios of 2.0X/2.0X, 2.5X/2.0X, 2.5X/2.5X were accumulated at unique positions along
the winding drum.

Film Formation
A 3.5% (w/v) 80/20 rMaSp1/rMaSp2 protein was dissolved in water with 0.1%
formic acid (Alfa Aesar) and 0.05% glutaraldehyde (Amresco) using the solubilization
procedure. Films were formed by pouring the solution onto PDMS strips (Dow Corning)
and allowing dehydration overnight. The films were removed and cut down to specific
sizes. Films were then mounted on a custom stretching device25 and soaked in varying
alcohol and water mixtures. Following at least 3 minutes of soaking they were then
stretched to 2.7X and 3X their original length, dried, and removed.

Adhesive Formation
The solubilization procedure is applied for all adhesive dopes, although dope
formulations varied between materials. Formulations for samples were as follows;
Wood: 20% (w/v) 50/50 rMaSp1/rMaSp2, 100mM Imidazole, 0.1% propionic acid, and
1% L-DOPA. Plastic and silicone: 12% (w/v) 50/50 rMaSp1/rMaSp2, 100mM Imidazole,
0.1% propionic acid, and 1% L-DOPA. The dope is then sprayed on the surface of the
material using the airbrush and compressor mentioned in the coatings section and the
same procedure. Finally, 50 µL of the adhesive solution is pipetted on substrate and the
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two pieces are then gently brought together and placed on a rack. The adhesives are
then dried in oven at 30 °C for 24 hours.

Hydrogel Formation
Using the solubilization procedure, a solution of 6% (w/v) 50/50 rMaSp1/rMaSp1
with 2% propionic acid (Alfa Aesar) is made. After solubilization the solution was
pipetted into a polypropylene tube (VWR) with a diameter of 15.5 mm upon a silicone
pad (MSC Industries). The gel was then covered and allowed to cure for one hour
before further processing.

Lyogel Formation
After the procedure for hydrogel formation, the hydrogels were taken and
placed into a dry tube. This container was then placed into a -20 °C freezer for at least 3
hours. Once the hydrogels were sufficiently frozen they were lyophilized at -80 °C and 1
Pa, for 24 hours.

Sponge Formation
After forming a hydrogel and placing it in a water bath it was transferred to a -20
°C freezer for at least 2 hours. The tube was removed and thawed to produce a rSSp
sponge.
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Foam Formation
A film solution was solubilized. The liquid was then aspirated using a l mL pipette
multiple times producing bubbles throughout the liquid. The sample was then left to
dry.

Coating Formation
A liquid dope containing 6% (w/v) 80/20 rMaSp1/rMaSp2, 1% propionic acid
(Alfa Aesar), and 100mM imidazole (Alfa Aesar) is solubilized. A layer of silk is applied
from 50 cm away for 15 seconds. This is repeated as necessary using three minute dry
times between layers. A G233 Master Airbrush with a 0.5 mm needle and nozzle
connected to a TC-60 Master Airbrush compressor is used for the application.

Mechanical Testing of Fibers
Single fibers were removed from the winding drum and mounted on C-cards.29
Five mounted fibers were produced for each stretch condition. The diameters of the
mounted fibers were measured using a Motic BA310 microscope with 10MP Motic
camera (Motic). Images were analyzed on Motic’s Image plus 2.0ML software.
Diameter measurements were made at three locations along the fibers axis and
averaged.
Measured fibers were then mounted on an MTS Synergie 100 with custom 10gram load cell (Transducer Techniques) by clamping the top and bottom of the C-card.
The cards were cut on the edge leaving only the fiber between the load cell and moving
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crosshead. Fibers were tested at 250 mm/min and 500 Hz collection rate using MTS’s
TestWorks 4, 2001. Data were exported to Microsoft Excel for energy to break, ultimate
stress and ultimate strain determination which was done for all of the testing described
below.

Mechanical Testing of Films
The films, as previously published25, are cut to a specific length and width. The
films are then mounted on a plastic C-card length wise using Loctite® super glue (liquid)
across an 8 mm gap. After mounting, the C-card is loaded on an MTS Synergie 100 (50N
load cell) by clamping the top and bottom of the film and card into the instrument with
alligator clips and then cutting the side of the C-card so the only thing being tested is the
film. The film is then tested to breaking at a stretch rate of 5 mm/min, with data
collection at 30 Hz to measure the film’s load in order to calculate stress, strain and
energy to break using MTS’s TestWorks 4, 2001.

Mechanical Testing of Adhesives
Wood samples were tested in a Tinius Olsen H50KS 50 kN using Tinius Olsen
utility software in the machine utility mode testing at 10 mm/min with data collection at
8 Hz, plastic was tested on a 250 N MTS Tytron 250 at 1.3 mm/min with data collected
at using Testworks4 to process information, the silicone was tested on an 50N MTS
Synergie 100 at 1.3 mm/min with readings taken at 30 Hz using TestWorks4, 2001 to
process information. Testing units were made by gluing samples together

66

(Supplementary Fig. S1) with the exception of the silicone samples, which were tested
without grip support. The samples are loaded into the instruments clamping on the
inside of the lips on the grip support.

Mechanical Testing of Hydrogels/Lyogels
Compressive mechanical tests were performed on the gels using an MTS
Synergie 100 equipped with a 50 N load cell and 50 mm diameter aluminum
compression platens using TestWorks 4 software. Prior to testing the gels, excess
moisture was removed by gentle wiping and the sample was placed directly in the
center of the platens. All tests were performed at room temperature with a test speed
of 1.3 mm/minute until ultimate failure of the gels occurred.

RESULTS
Aqueous Solubilization and Formation
By sealing the rSSps in a vial with water and microwaving the vial for 15-60
seconds, we are able to solvate all rSSps (goat produced rMaSp1 and rMaSp2,
bacterially produced native-like sequences MaSp116 and Piri4 (piriform silk), and
bacterially produced chimeric sequences FlYS, FlYS3, FlAS, FlAS3, and A4S88: supporting
information) attempted to date.22–24 The materials made (Figure 1) and all other data in
this manuscript were produced from goat produced rMaSp1 and rMaSp2. The quick
generation of heat, pressure, and potentially the known effect of microwaves spinning
polar water molecules solvates up to 40% w/v rSSps solutions in a short period of time.
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The method is water based, so it is environmentally friendly and non-toxic; for this
reason, the use of water as the solvent also allows for easy and practical scalability.
The speed and efficiency of the method also provides a previously unknown level
of versatility with respect to processing and the ability to form various materials.
Fabrication and production of fibers, films, sponges, hydrogels, lyogels, foams, coatings,

Figure 1. Aqueous method products. Schematic array of spider silk materials formed
from the aqueous based solvation method. All materials are formed from lyophilized
rSSps and water.

and adhesives can be achieved within a relatively short time (minutes to hours),
depending on protein concentration, treatments, and desired final material. Within
these final formations, it is possible to create tunable or custom features such as
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variations in stress, strain or porosity by alterations to additives and post-formation
treatment.25 By using these variations, specific materials can be formed and
constructed that are suitable for a variety of applications including sporting gear,
industrial equipment, tissue engineering, or medical devices.26–28
Mechanical properties are the major focus of fibers, films, adhesives, and to
some extent gels produced from this aqueous method. However, coatings, foams, and
sponges are not expected to contribute substantially to a final product’s mechanical
properties. Rather, functionality and biocompatibility of coatings, foams, and sponges
are the desired properties. The remaining categories of hydrogels, lyogels, fibers, films,
and adhesives have all been tested mechanically (Figure 2). The secondary structure of
fibers, films, sponges, lyogels, hydrogels, and the liquid dopes were also examined using
FTIR-ATR spectroscopy (Figure S2). The structural findings indicate that the purified
rSSps powder is predominantly β-sheet, the solubilized liquid rSSps dope is in a largely
helical conformation that converts to a β-sheet rich material as the dope sets into its
final solid form, similar to the transformation seen with 1,1,1,3,3,3Hexafluoroisopropanol (HFIP) based dope solutions or when an alcohol/water treatment
is applied to HFIP-processed materials.25

Aqueous-Based rSSps Fibers and Films
Fibers and films are two materials that are frequently sought for silk derived
products and often these materials have the most appreciable mechanical
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Figure 2. Mechanical properties of rSSps products. (A) A stress-strain graph of fibers
(solid) and films (dashed) with maximum stress (blue), maximum strain (orange) and
maximum energy to break (red). (B) Stress-strain graph of adhesive of spider silk protein
on wood substrates of walnut (orange), oak (blue) and zebra wood (red). (C) A stressstrain graph of compressive properties of a lyogel (red) and a hydrogel (blue). (D) Stressstrain graph of adhesive rSSps on polycarbonate (blue), polypropylene (orange) and
silicone (red).

properties.19,25,29,30 The applications for these products range from protective materials
to composites. Fibers and films can be used in the medical field to replace tendons or
skin.31,32 Published reports indicate maximum stress and strain of 508 MPa and 15% for
fibers and 54 MPa and 13% for films with the silk dissolved in HFIP.10,25
Our method of solubilizing and spinning or casting films more closely mimics a
spider’s method, which does not involve organic solvents. Both films and fibers can be
produced from the aqueous method (Figure 2A) Fiber mechanical properties that rival
natural silks with ultimate stress values that approach 300 MPa and strains as high as
64%. Further refinement of spinning conditions and processing conditions will allow for
improved mechanical ability of fibers. Films have also been produced with mechanical
properties exceeding those of all other rSSps films reported with an ultimate stress as
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high as 200 MPa and strain approaching 120%.25 Strength is not the only impressive
property for aqueous derived films and fibers; both the stress and strain of the materials
can be manipulated to customize the mechanical properties to desired specifications.
Also, fibers and films can be designed for high energy to break by varying the ratios of
the rMaSp1 to rMaSp2 and stretching the fibers and films thus improving β-sheet
alignment along the longitudinal axis.25,29

Aqueous-Based rSSps Adhesives
Adhesives are used extensively today. Spiders and other organisms use natural
adhesives, glyco-proteins, and proteins, to assemble or fasten their webs or
structures.33–35 The same solutions that can be used to form fibers, films, gels, and
coatings can create an adhesive as well. Using this aqueous method with rMaSp1 and
rMaSp2, the solvated solutions can be used to produce rSSps glues without modification
of the method or additional preparation. Due to the water based nature of this specific
process the adhesives could be used within biological systems, for example, wound or
surgical repair.
The solvated silk solutions were used as an adhesive on several substrates
(Figure 2B,D) and tested in different loading conditions such as normal tension,
compressive shear, and tensile shear (Figure S3). When these adhesive formulations are
applied to substrates as a liquid, the surface is sufficiently wetted and covered by the
solution allowing the adhesive to penetrate and fill cracks or pores. The rSSps adhesives
are able to glue silicone materials together, with stresses exceeding 60 KPa and strain
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values near 30%, mostly due to silicone’s elasticity, which demonstrates the ability of
the adhesives to stretch without failure (Table 1).
Table 1. Mechanical properties of different rSSp products with the mean represented
followed by the standard deviation (SD) of each value.
Product

Stress
(MPa)

Strain
(%)

Fiber
Film
Hydrogel
Lyogel
Adhesive-Wood
Adhesive-Plastic
Adhesive-Silicone

192.2 ± 51.47
183.9 ± 14.85
0.13 ± 0.007
0.89 ± 0.038
12.4 ± 2.52
0.93 ± 0.23
0.057 ± 0.005

28.1 ± 26.0
35.4 ± 7.0
31.0 ± 3.0
73.0 ± 2.6
15.4 ± 9.9
16.4 ± 2.8
31.0 ± 3.6

Energy to
Break
(MJ/m±3)
33.77
52.36
33.552± 8.02
0.043 ±
0.251
0.002 ±
1.31
0.013± 1.15
0.042 ±
0.011
0.016 ±
0.002

Glued wood samples match or surpass the strength of conventional wood glues
for most samples with stress values as high as 15 MPa and strains that approach 15%,
Elmer’s wood glue has maximal stress values around 10 MPa and elongations that only
approach 8% before failure in our system (Figure 2B). Gorilla Glue™, a conventional
adhesive with maximum stress values of 1 MPa and elongations of 3%, is substantially
outperformed on all wooden substrates by the rSSps adhesives by up to an order of
magnitude with stress values of 10 MPa and strains of 17% (Video S1). As a result of the
increased stress and strain, these rSSps adhesives have a higher energy to break than
both control adhesives tested. The maximum results for the rSSps adhesives and
Elmer’s wood glue previously discussed had energy to break values of 3 MJ/m3 and 0.7
MJ/m3, respectively. This increased toughness, approximately 430 % greater than
Elmer’s wood glue and 1300% for Gorilla Glue™, is due to the ability of the aqueous
based rSSps adhesive to stretch under load (15% strain) instead of suddenly failing

72

without deformation of the glue (8% strain Elmer’s wood glue and 3% strain for Gorilla
glue™).

Aqueous-Based rSSps Gels
Hydrogels, lyogels, and sponges could not to be formed from spider silk proteins
dissolved in HFIP but are readily formed with our aqueous method. The hydrogels,
which are primarily composed of water (80% to 97%), are able to withstand compressive
stresses up to 140 KPa and maintain their structural integrity and shape outside of a
liquid suspension (Figures 2C and 3A,B). The internal organization of the hydrogels can
also be varied with the use of certain treatments that induce secondary structures
(reported below) within the gel (Figure S2). Other recombinant spider silk protein
hydrogels have been reported in the literature with mechanical rheological stress and
strain of 250 Pa and 30% respectively, but no normal compressive tests have been
reported. These hydrogels were generated by a dialysis method to increase protein
concentrations and remove the solubilizing agent.16
Lyogels are lyophilized hydrogels that possess similar traits to hydrogels but have
unique mechanical properties.36, 37 Like hydrogels, lyogels are dimensionally stable and
maintain their structural stability. They can also be manipulated with post-formation
treatments to alter secondary structures and macrostructures within the gel (Figure 3C).
Unlike hydrogels, lyogels are able to resist mechanical loading to a greater extent with
stresses approaching 300 KPa and strain near 40%, while being composed of primarily
air and spider silk protein (Figure 2C). Lyogels are also able to absorb water with relative
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ease, up to approximately 1600% of the original dry weight (Video S2). Although others
have been able to produce both spider silk and silkworm silk derived lyogels, rarely are
mechanical properties reported.36,38,39
A third possible material derived from a hydrogel is a rSSps sponge with distinct
mechanical properties from both hydrogels and lyogels (Figure 3D-H). Sponges are

Figure 3. Spider silk protein gels and sponges. (A) rSSps hydrogel. (B) rSSps hydrogel
with shape variation and stability. (C) rSSps lyogel. (D) rSSps sponge after fabrication. (E)
Compressive loading of sponge and the release of water. (F) Recovery of the sponge
after removal of compressive load. (G) A compressed and dehydrated sponge. (H)
Compressed sponge maintaining the dehydrated shape without loading. (I) Rehydration
of the compressed sponge.

formed by freezing a hydrogel in the presence of water and then allowing the hydrogel
to thaw. No mechanical testing was done for sponges due to their ability to deform and
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recover when rehydrated or unloaded. A silk sponge is able to go through several
mechanical loadings and unloadings and recover (Figure 3) with the simple addition of
water, which is absorbed into the silk matrix and returns the sponge to its original
formation similar to shape memory. Compressed sponges maintain their shape when
the compressive load is removed. It is only the addition of water that restores the
original dimension of the sponge.
Gels and gel-derived products have proven promising in their ability to foster
and support cell growth. Goat fetal fibroblast cells grown on the hydrogels show a
healthy appearance and do not appear to be disturbed by the presence of the gel
(Figure S4). This property is particularly important when considering this method of
producing aqueous based gels for medical implant applications.
The secondary structures of the hydrogels, lyogels, and sponges, determined by
FTIR-ATR spectroscopy, help explain the properties and abilities of the materials (Figure
S2). When the spectra of hydrogels and lyogels are analyzed, distinct peak signatures
are seen in the regions that correlate with β-sheet structures while random coils and
helical regions are not as prevalent. This protein secondary structure relates to the
rigidity and strength of the hydrogels and lyogels and their ability to resist or maintain
their structure when compressed. However, the spectra of the sponges show that the
β-sheet regions although still present, are no longer as prevalent. The increase in
random coil and α-helices indicates why the sponge material is able to deform from a
cylinder into a wafer through the expulsion of water, maintain the wafer shape in the
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absence of compressive force, then reform to its original dimension through
reabsorption of water (Video S3).

Aqueous-Based rSSps Foams and Coatings
Other materials generated from this aqueous method that are less mechanically
oriented are foams and coatings. A foam is a mass of small bubbles formed on or in =

Figure 4. Various rSSps coatings. (A) An unbent silicone catheter 1.1 mm diameter
coated with rSSps. (B) Silicone catheter while bent into a circle with a diameter of 2.5
cm. (C) Catheter straightened to its original form. (D) rSSps coated wafer with the
coating applied to the left half. (E) SEM cross-sectional image of a rSSps coated wafer
with an approximate thickness of 2 µm. (F) SEM cross-sectional image of a rSSps coated
catheter with an approximate thickness of 5 µm. (G) rSSps coated silicone wafer
functionalized with kanamycin that produced zones of inhibition approximately 22 mm
in diameter on E. coli. (H) rSSps coated catheters loaded with kanamycin and zones of
inhibition approximately 2.5 mm from the catheter on E. coli. (I) rSSps coated stainless
steel functionalized with kanamycin and zones of inhibition approximately 20 mm in
diameter on E. coli. (J) rSSps coated silicone wafers functionalized with an azole and
zones of inhibition approximately 16 mm in diameter on C. albicans.
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liquid. Foams can be used to decrease internal bleeding in trauma victims or as a cell
growth matrix for research purposes (Figure 1).31, 32 Coatings have immense potential
and may be appropriate for applications such as coatings on catheters, stents, and other
medical devices that would benefit from a biocompatible, functionalized coating (Figure
4).
These rSSps coatings can be applied to almost any substrate by simply
administering the solubilized liquid to the surface of a substrate using an aerosolized
spray, pouring, or with a submerging dip technique, depending on the application and
desired surface properties. The thickness of the coating can also be varied and coatings
thinner than 1 μm and as thick as 50 μm have been produced by these methods. Spider
silk protein coatings are intriguing for several other reasons, the first of which is the high
adherence to most surfaces, especially materials that traditionally resist coatings like
medical grade silicones.40 Another interesting feature is the ability of the rSSps coatings
to resist separation upon bending or stretching and even recover from deformation
from bending. This is illustrated in Figure 4: panel A is an unbent rSSps coated catheter
1.1 mm diameter; panel B is a bent rSSps coating catheter showing compression
buckling lines at a 2.5 mm diameter bend; and panel C is a straightened, post-bent
coated rSSps catheter showing that no cracking or breaking occurs, although minor
buckling lines still remain.
A final feature is that the coatings form a biocompatible and protective layer
that can be constructed to contain additives, like antibiotics, antimycotics, antiinflammatory drugs or growth factors, which inhibit or enhance certain biological
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processes. The rSSps coatings (Figure 4) contain the antibiotic kanamycin, which proved
successful in preventing the growth of Escherichia coli for as long as two weeks as
indicated by zones of inhibition around the coated silicone wafers. Common implant
materials, silicone and stainless steel, have both been successfully coated and
functionalized (Figure 4G-J). The dosage of an additive can be adjusted within the
coating formulation to produce the desired inhibition and response (Figure 4G-J)
without affecting the ability of the rSSps to coat the material. This functionalization of
the coating has also been demonstrated against other organisms such as the yeast
Candida albicans. Silicone wafers coated with rSSps containing antimycotic drugs
produced a zone of inhibition when exposed to Candida albicans, further demonstrating
the functionality of these coatings (Figure 4J).

DISCUSSION
Recombinant spider silks may offer potential solutions for a vast number of
industries and applications. The various aqueous based materials presented here offer
new options and possibilities for these applications. This investigation was mostly a
broad approach that primarily focused on the mechanical and structural properties of
the materials. Optimizations were then performed for each material to maximize these
properties and determine the ranges of tunable features that were possible. It was
determined through mechanical and structural analysis that most of these materials can
be customized for a specific function.
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The efficiency and speed of this solubilization method further increase the
potential of rSSps materials. The method of solvating rSSps presented here is quick and
results in nearly 100% solvation and recovery of solubilized rSSps. This method unlocks
previously problematic or unattainable solutions and broadens the scope of rSSps
beyond fibers into films, foams, gels, sponges, adhesives and coatings. No other single
solubilization method exists from which this variety of formulations can be generated
from a single rSSps and maintain the desirable characteristics of biocompatibility and
mechanical abilities while being green and economically responsible. Furthermore, this
aqueous method also allows for diverse functionalization of the rSSps, regardless of final
forms, to allow for wound healing, implantation and tissue growth that was not
available with materials based from HFIP or other organic solvent solutions. This initial
inquiry into the possibilities of water-based recombinant spider silk materials
demonstrated the effectiveness and initial possibilities for such materials.

CONCLUSIONS
This study has demonstrated the ability to take rSSps and solubilize them for
various applications using water as a solvent. This aqueous solvation method which is
safe and environmentally friendly brings recombinantly produced spider silks one step
closer to commercial and large-scale uses. The use of water as the solvent mimics a
spider and removes the need for costly and caustic organic solvents. Additionally, this
novel process has only one major step that can be completed in a matter of seconds
with a variety of solutions. Not only is this process time efficient but it has results in
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nearly 100% protein solubilization, which allows for greater recovery. Finally, this
process has allowed for a diverse profile of aqueous derived materials to be created.
Common materials such as fibers and films are still possible from the aqueous method
but more exotic materials like hydrogels, adhesives, lyogels, coatings, foams, and
sponges are now possible. The reveal of this method is accompanied by
characterization of these materials and their potentials.

SUPPORTING INFORMATION
Protein sequences, coomasie gel of preparation methods, comparative FTIR
spectra, adhesive schematic, hydrogel cell culture figures, and related methods along
with videos of adhesives, lyogels, and sponges. This material is available free of charge
via the Internet at http://pubs.acs.org.
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CHAPTER 4
CONCLUSION

Recombinant spider silk protein (rSSp) has been limited in its ability to enter the
materials landscape for two major reasons. The first is that it is very difficult to produce
the rSSp regardless of transgenic system due to the highly repetitive nature of the silk
proteins. Their underlying nucleic acid sequences cause significant problems both
during transcription and translation and their protein sequences often cause
aggregation issues once translated. The second reason is that traditional methods of
solvating rSSp’s in order to produce fibers and films require very harsh organic solvents
such as HFIP. While others work to solve the expression issues of rSSp, this dissertation
sets forth a new, quick and scalable method for the solvation of rSSp in water with near
100% solvation and recovery. The method is also scalable with common chemical
engineering techniques.
By placing normally sparingly soluble rSSp into a sealed vial with water and then
generating heat and pressure using a conventional microwave, all rSSp protein dopes
attempted to date have been solvated. From those solutions fibers, films and foams
have been created. As a byproduct of the aqueous method several new materials
composed of rSSp have been achieved including hydrogels, lyogels, adhesives, coatings
and even a never reported in the literature material, a sponge. All are unique both
mechanically as well as in potential applications. Fibers have obvious benefit to the
performance thread or material markets as well as in very fine sutures. The mechanical
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properties demonstrated by the materials included in this thesis are remarkable in that
they are comparable to fibers derived of the same protein from the conventional, but
toxic HFIP solvation and spinning methods. With further development and refinement
of the spinning process, and particularly with post manufacture processing, these fibers
will continue to improve.
Recombinant spider silk thin films have also been accomplished through this
solvation method. These films, like the fibers, were comparable if not better than films
produced from identical proteins using HFIP as a solvent. Films are an intriguing product
from rSSp. Biocompatible, flexible, functionalizable (ability to incorporate antibiotics,
antimycotics, steroids etc) and strong, these thin films could serve a variety of uses such
as cell growth matrices, wound repair substrate and degradable, flexible coatings on
medical devices. Coatings are a derivation of films that are also potentially useful.
Coatings can be produced by dipping the material into an aqueous rSSp solution or by
spray coating. Every material attempted to date has been successfully coated including
medical grade silicon and stainless steel. Again, the biocompatibility and
functionalizable nature of these coatings, tunable cell adhesion1 as well as their diverse
range of coatable materials, make them an intriguing option for coating medical devices
such as intravenous and urethral catheters to control infection, clotting (I.V.) and cell
adhesion.
The adhesives properties of these protein based rSSps is remarkable from
aqueous solutions. When compared to standard Elmer’s glue and Gorilla glue, our glues
perform as well as and better than both depending on the substrate, with Gorilla glue
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being substantially outperformed on all substrates in our tests. (Data not shown)
Interestingly, spiders produce 7 different proteins from their silk producing glands, one
of which is an adhesive like protein produced from the aggregate gland.2 This protein
adhesive is highly glycosylated, similar to a mucin, and those carbohydrates provide the
adhesive properties. The two proteins used in our adhesive studies are the two proteins
that comprise the dragline silk, MaSp13 and MaSp24 and the spider does not use them
as an adhesive in any known situation. The fact then that these two proteins alone or in
combination can form an adhesive, and a mechanically robust adhesive at that, is
remarkable and clearly broadens the scope of materials able to be produced from the
same starting material as is used to produce the other materials presented in this thesis.
Finally, the gels and a new material, a sponge provide unique characteristics and
potential applications. Hydrogels and lyogels have been reported from rSSp in the
literature.5,6 The difference between the gels produced from this aqueous method and
others is dimensional stability, speed of formation and tunable properties. Reported
hydrogel and lyogel formation (lyogels are lyophilized hydrogels) take many hours to
form.7
In our method, hydrogels can be formed in minutes or the composition of the
proteins and or additives altered to delay gelation. As well, by altering protein
concentrations and compositions as well as post-pour treatments (EtOH, MeOH, IPA)
the pore size and mechanical ability of the gel can be altered or tailored to a specific
application. Sponges, a frozen and then thawed hydrogel, are an entirely new material
application for rSSp and one that has to our knowledge ever been reported in the
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literature. The sponge attributes are that it can be compressed to expel water and it
remains in the compressed state until water is reapplied to the gel. In thinking about
possible uses for such a material one quickly arrives at tissue regeneration matrices.
The ability to form a sponge, remove the water, and then allow the sponge to absorb
ascites fluid and stem cells to promote regeneration in whatever tissue implanted. The
sponges are robust enough to be sutured in place in such applications as nerve and
blood vessel regeneration.
To wrap up the project, and this dissertation, I prepared a table (Table 1) of all of
the developments that have resulted from this aqueous solvation method and where
the project currently stands in terms of science, publication and funding.
Table 1: Aqueous based materials current/future work with publications and funding.
Technology
Current
Future
Publication Funding
Fibers +
Films

Gels +
Sponge

--Improve solvation
technique and
understand additives
--Cross-linking to
improve mechanical
performance
--Gelation rate control
--Cross-linking
--Sponge formation tech
--Drug release
--3D printing

Biological --Complete vaccine study
Stabilization (March 2015)
Coatings +
Adhesives

--Characterization
--Basic application
techniques

February
2015
Films
published
2014

JRA with
industry
partners.
SBIR
(Phase I
completed)

March-April
2015

None
current
and no
immediate
source.

--Broaden scope of
proteins
--Include other
industrial partners

??-IP
concerns

SBIR/STTR
March
2015
JRA

--Rate control
--I.V. experiments for
biofouling and clotting

April-May
2015

STTR April
2015

--Multi-head spinning
from bacterially derived
proteins

--Biocompatibility
--Targeted drug release
in-vivo
--Sponge cell seeding
--Directed nerve
regeneration
--3D printing
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The development of an aqueous based method of solvating normally water
insoluble rSSp was a needed advancement in the spider silk community that has
unlocked potential that, prior to its development, was not possible or realized. As a
result, patents and scientific manuscripts have been submitted or published and funding
sources unlocked to develop these new spider silk materials as well as continue to
develop fibers. Continued research on fibers and films to improve spin and post-spin
conditions will continue. Funding for this research has been secured through a joint
research agreement with an industry partner as well as a successfully completed SBIR
phase 1 grant. Phase 2 of the SBIR process is set to be submitted in March of 2015.
Gels (hydrogels, lyogels and sponges): We will continue to develop the process of
forming the gels and sponge through understanding the basic protein chemistry
occurring that causes gelation in an attempt to control the rate of gelation, the pore
sizes produced as well as the mechanical ability. A paper will be published in March or
April of 2015.
Biological stabilization will continue with a vaccine stabilization study with an
industry partner in March of 2015. At the conclusion of that study, a determination will
be made on how to proceed, either production of the protein for stabilization or an
SBIR/STTR to continue the research or both. Coatings and adhesives: The rate of
adhesion will continue to be explored through additives to the aqueous solutions, such
as isopropanol. Currently, the adhesion rate is too slow to be viable in most real-world
applications. As well, the exploration of what additives can be included in an adhesive
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or coating will continue as guided by a request for proposals for an SBIR/STTR
submission regarding both intravenous and urinary catheter coatings. A preliminary
scientific manuscript is in preparation for submission in April or May of 2015 with the
SBIR/STTR phase 1 proposal slated for submission in April of 2015.
An aqueous solvation method for rSSp has been achieved. Through this
advancement fibers, films, coatings, gels and sponges have been formed and
characterized. This advancement is not the only advancement required to propel rSSp
(in some form) into industrial applications. While more work is needed to solve supply
problems, a method now exists to take rSSp and formulate it through a green,
sustainable process.
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APPENDIX C
SYNTHETIC SPIDER SILK PROTEIN
COMPOSITIONS AND METHODS1

1. Lewis, R. V. & Jones, J. A. SYNTHETIC SPIDER SILK PROTEIN COMPOSITIONS
AND METHODS. (2015). U.S. Patent Application 2015/0047532
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TECHNICAL FIELD
The present disclosure relates to synthetic spider silk protein compositions.
More specifically, the present disclosure relates to aqueous solutions of recombinant
spider silk proteins (“rSSP”) and synthetic spider silk protein compositions made from
such aqueous solutions.
SUMMARY
The present disclosure in aspects and embodiments addresses these various
needs and problems by providing a method of solubilizing recombinant spider silk
proteins (rSSP) in an aqueous solution and related compositions. Exemplary methods
include mixing rSSP with water to form a mixture, and microwaving the resulting
mixture to form a solution. Optional steps also include, sonicating the mixture,
centrifuging the solution, sonicating the solution, and adding various additives to the
mixture. Suitable additives may be configured to decrease gel formation of the
solution.
In one aspect, a method of solubilizing one or more recombinant spider silk
proteins in an aqueous solution is disclosed, which includes mixing the one or more
recombinant spider silk proteins with water to form a mixture in a sealed container and
heating the mixture to form a solution.
In some embodiments, heating is performed with microwave irradiation. In some
embodiments, the method includes sonicating the mixture. In some embodiments, the
method includes sonicating the solution. In some embodiments, the method includes
centrifuging the solution.
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In some embodiments, the method includes providing additives for reducing gel
formation in the solution. In some embodiments, the additives are selected from the
group consisting of: an acid, a base, free amino acids, surfactants, and combinations
thereof. In some embodiments, the additives are selected from the group consisting of:
propionic acid, formic acid, acetic acid, ammonium hydroxide, L-arginine, L-glutamic
acid, β-mercaptoethanol, dithiothreitol, and combinations thereof.
In some embodiments, the one or more recombinant spider silk proteins are
selected from the group consisting of: M4, M5, MaSP1, a MaSP1 analogue, MaSP2, an
MaSP2 analogue, and combinations thereof.
In some embodiments, the ratio of the one or more recombinant spider silk
proteins to water in the mixture is from 1:10 to 1:2.
In some embodiments, the method includes obtaining a recombinant spider silk
protein fiber from the mixture. In some embodiments, the method includes stretching
the fiber. In some embodiments, the method includes obtaining a recombinant spider
silk protein material from the mixture. In some embodiments, the method includes
stretching the material.
In another aspect, recombinant spider silk protein materials prepared using
techniques disclosed herein, where the material has the form of a hydrogel, lyogel, film,
coating, foam, fiber, and combinations thereof. In some embodiments, the material is a
hydrogel. In some embodiments, the material is a lyogel. In some embodiments, the
material is a film. In some embodiments, the material is a coating. In some
embodiments, the material is a foam. In some embodiments, the material is a fiber.
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In another aspect, an aqueous solution of recombinant spider silk proteins is
disclosed having one or more recombinant spider silk proteins and water, wherein the
amount of the one or more recombinant spider silk proteins is greater than about 2%
w/v. In some embodiments, the amount of the one or more recombinant spider silk
proteins is less than about 50% w/v.
In some embodiments, the solution includes one or more additives for reducing
gel formation. In some embodiments, the one or more additives are selected from the
group consisting of: an acid, a base, free amino acids, surfactants, and combinations
thereof. In some embodiments, the one or more additives are selected from the group
consisting of: propionic acid, formic acid, acetic acid, ammonium hydroxide, L-arginine,
L-glutamic acid, β-mercaptoethanol, dithiothreitol, and combinations thereof.

BRIEF DESCRITPION OF THE FIGURES
Figure 1A illustrates an exemplary recombinant spider silk fiber prepared
according to one embodiment.
Figure 1B illustrates an exemplary recombinant spider silk fiber prepared
according to one embodiment.
Figure 2 is a schematic representation of gluing boards used to characterize one
embodiment.
Figure 3 is the hysteresis testing results on hydrogels according to one
embodiment.
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Figure 4 is a silicon wafer Purple (darkest shading) spider silk coated silicon wafer
with methyl violet; next clockwise: control with spider silk coating and without
kanamycin; next clockwise: Spider silk coating with 50mg/L kanamycin; next clockwise:
spider silk coating with 250mg/L kanamycin; next clockwise: spider silk coating with
500mg/L kanamycin. Bacterial lawn is E. coli XL-1 blue cells.
Figure 5 is depiction showing silicon urinary catheters (3 french) coated with
spider silk protein (top), spider silk coating loaded with 50mg/L kanamycin (middle) and
spider silk coating loaded with 500mg/L kanamycin (bottom) according to one
embodiment on a lawn of bacteria.
Figure 6 is depiction showing a stainless steel plate that was dip coated with
recombinant spider silk protein according to one embodiment.

DETAILED DESCRIPTION
The present disclosure covers methods, compositions, reagents, and kits for
making aqueous solutions of rSSP and for synthetic spider silk protein compositions
derived from such solutions.
In the following description, numerous specific details are provided for a
thorough understanding of specific preferred embodiments. However, those skilled in
the art will recognize that embodiments can be practiced without one or more of the
specific details, or with other methods, components, materials, etc. In some cases, wellknown structures, materials, or operations are not shown or described in detail in order
to avoid obscuring aspects of the preferred embodiments. Furthermore, the described
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features, structures, or characteristics may be combined in any suitable manner in a
variety of alternative embodiments. Thus, the following more detailed description of
the embodiments of the present invention, as illustrated in some aspects in the
drawings, is not intended to limit the scope of the invention, but is merely
representative of the various embodiments of the invention.
In this specification and the claims that follow, singular forms such as “a,” “an,”
and “the” include plural forms unless the content clearly dictates otherwise. All ranges
disclosed herein include, unless specifically indicated, all endpoints and intermediate
values. In addition, “optional” or “optionally” refer, for example, to instances in which
subsequently described circumstance may or may not occur, and include instances in
which the circumstance occurs and instances in which the circumstance does not occur.
The terms “one or more” and “at least one” refer, for example, to instances in which
one of the subsequently described circumstances occurs, and to instances in which
more than one of the subsequently described circumstances occurs.
The present disclosure covers methods, compositions, reagents, and kits for
making aqueous solutions of rSSP and for synthetic spider silk protein compositions
derived from such solutions.
rSSP’s are conventionally dissolved in a very harsh organic solvent, 1,1,1,3,3,3hexafluoroisopropanol (HFIP), to create “dopes” that can be used to create fibers, films,
gels and foams. HFIP has been widely used and accepted as it is the only solvent that: 1)
dissolves rSSP’s at high concentrations (30% w/v) providing uniformity between various
groups testing data, 2) is sufficiently volatile and miscible to be removed rapidly from
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the forming fiber, 3) leaves little to no residue behind that could interfere with fiber
formation. In addition, rSSP’s generally are insoluble in aqueous solutions after
purification, necessitating an organic solvent that meets the criteria outlined in 1-3.
However, there are significant problems with solvating rSSP’s in HFIP or other organic
solvents.
Dissolving rSSP in HFIP and then using pressure to extrude the dope into a
coagulation bath does not allow the appropriate structures to form (notably β-sheets) to
an extent that the fibers or films have to be post-spin processed multiple times to
achieve protein structures that result in appreciable mechanical properties. See Lazaris
et al., Spider Silk Fibers Spun from Soluble Recombinant Silk Produced in Mammalian
Cells, Science 295, 472-476 (2002) (hereinafter “Lazaris”); and Teule et al., Modifications
of spider silk sequences in an attempt to control the mechanical properties of the
synthetic fibers, J. Mater Sci, 42, 8974-8985 (2007) (hereinafter “Teule”).
Such fiber processing methodologies include extruding the fiber into a
coagulation bath that may include pure isopropanol or a mixture of isopropanol:water.
The fiber may then be stretched (1.5-6X) in a second bath generally containing a mixture
of isopropanol:water. A third bath may also be employed that contains pure water or a
majority of water, and a second stretch applied in that bath. Water is the recurrent
theme in these baths and it is the water that converts the helical structures present due
to HFIP into strength providing β-sheets.
The cost of purchase and subsequent disposal of HFIP may be restrictive or
prohibitive in an industrial setting of mass production. HFIP’s cost of purchase is
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roughly $1,000 / 100ml’s of HFIP and 100ml’s of HFIP would likely be capable of
solvating 20-30g’s of rSSP (20-30% w/v). Water is cheap even in its purest form. Per the
MSDS published on Sigma Aldrich’s web-site, disposal of HFIP requires; “Dissolve or mix
the material with a combustible solvent and burn in a chemical incinerator equipped
with an afterburner and scrubber,” a process that inherently has costs associated with it.
Excess water can be evaporated or recycled and reused. Worker safety when utilizing
such harsh, volatile solvents is also a consideration. Per the MSDS; “Material is
extremely destructive to tissue of the mucous membranes and upper respiratory tract,
eyes, and skin. Cough, Shortness of breath, Headache, Nausea” (SIC). Water has no such
requirements. Finally, the process of producing rSSP products could not be considered
“green” using HFIP.
rSSP’s are largely insoluble in water. There are a few notable exceptions: Teule
describes a series of proteins (Y1S8 and A2S8) that were produced in bacteria and purified
via Ni++ chromatography. Short fibers were pulled straight from the eluted, pure rSSP
fraction. See Teule. Lazaris describes ADF-3 (Araneus diadematus MaSp1) produced in
mammalian cell culture. Water soluble ADF-3 was concentrated in the presence of
glycine and extruded into a coagulation bath. A final example is a series of recombinant
aciniform-like synthetic proteins that were able to be spun from an aqueous solution
very similar to Teule 2007 (Xu 2012). See Xu et al., Recombinant Minimalist Spider
Wrapping Silk Proteins Capable of Native-Like Fiber Formation. PloS-One 7(11): e50227.
Doi: 10.1371/journal.pone.0050227 (2012). However, outside of this small sub-set of
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rSSP’s, water solubility is elusive. The majority of these proteins were much smaller
than the natural proteins and thus are unlikely to make mechanically useful fibers.
U.S. Patent Application Publication No. 2011/0230911 filed by Amsilk utilizes a
top down approach: genetic manipulations and expression system manipulations to try
and create water soluble silk proteins. However, such processes are costly both in time
to create the manipulations/cell lines and also in that the proteins appear to be
expressed in mammalian cell cultures. The culture conditions for such cell lines are not
only personnel and time intensive but also the ingredients and equipment are
substantially more expensive than the more traditional bacterial expression systems. In
addition, such methods are limiting as there are not that many iterations of various
spider silk repeats that can be expressed in this manner that will result in a water
soluble protein that has appreciable mechanical properties.
To address these and other challenges, this disclosure sets forth new and novel
methods for solubilizing rSSP’s in aqueous solutions and then creating resulting spider
silk compositions therefrom. The methods and compositions described herein in
embodiments create aqueous dopes from rSSPs that are otherwise not soluble in water.
The methods and compositions described herein may be applied to proteins expressed
by any organism, reducing the cost of production and also possibly improving the
mechanical properties of the fibers, films, gels and foams by the inclusion of water in
the dope.
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In embodiments, methods of preparing aqueous dopes of rSSP may include the
following steps: mixing rSSP, water, and optional additives; optionally sonicating the
mixture; microwaving the mixture; and optionally centrifuging the microwaved mixture.
Aqueous Dopes. rSSP and water are combined to create a doping mixture of
greater than about 2% w/v (e.g. 0.02g SSpS : 1 mL H2O). In embodiments, the w/v does
not typically exceed 50%. However, any percentage of less than 50% may be used.
Suitable rSSP’s include: MaSp1 (as described in US Patent Nos. 7,521,228 and
5,989,894), MaSp2 (as described in US Patent Nos. 7,521,228 and 5,989,894), MiSp1 (as
described in US Patent Nos. 5,733,771 and 5,756,677), MiSp2 (as described in US Patent
Nos. 5,733,771 and 5,756,677) , Flagelliform (as described in US Patent No. 5,994,099),
chimeric rSSP’s (as described in US Patent No. 7,723,109), Pyriform, aciniform,
tubuliform, aggregate gland silk proteins, and AdF-3 and AdF-4 from araneus
diadematus. Each of the above referenced patents is herein incorporated by reference
in its entirety.
Dope Additives. Various optional additives may be optionally added to the
mixture. Suitable additives include compositions that contribute to the solubility of the
rSSP in the solution. Some additives break or weaken disulfide bonds, thereby
increasing the solubility of rSSP’s. Other additives also serve to prevent hydrogel
formation after the completion of the microwave step, as set forth below. If the
solution forms a hydrogel quickly and the desired end product is not a gel, then
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additives capable of delaying or inhibiting such a formation may be desirable. In some
embodiments, multiple additives may be added to achieve desired end products.
For example, to combat hydrogel formation, various additives may be added to
the suspension of rSSP and water prior to microwaving the suspension. In some
embodiments, acid, base, free amino acids, surfactants, or combinations thereof may be
employed to combat hydrogel formation. For example, additions of acid (formic acid
and acetic acid alone or together at 0.1% to 10% v/v), base (ammonium hydroxide at
0.1% to 10% v/v), free amino acids (L-Arginine and L-Glutamic Acid at 1 to 100mM) as
well as a variety of surfactants (Triton X-100 at 0.1% v/v) may be used. The additions of
these various chemicals not only aid the solubility of rSSP when microwaved but in
certain combinations also delay the solution from turning into a hydrogel long enough
for the solution to be spun into a fiber.
By altering and adjusting the combinations of additives to the dopes, the
mechanical properties of the spun fiber are significantly impacted. For example, too
much acid or base may result in fibers that are brittle with little to no extensibility; too
little acid or base may result in dopes where the rSSP will not solubilize to the extent
necessary for fiber spinning or turns to a hydrogel quickly.
Exemplary additives also include compositions capable of breaking or weakening
disulfide bonds, such as β-mercaptoethanol or dithiothreitol may be added to reduce
bonds and increase solubility. Suitable amounts of such additives may include from
about 0.1 to about 5% (v/v). In embodiments where the rSSP does not contain cysteine,
the use of such additives may be unnecessary. In some embodiments employing major
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ampulate silk proteins 1 and 2 (MaSp1 and MaSp2, respectfully), disulfide bonds
(cysteine) are present in the C-terminus of the non-repetitive regions of MaSp1 and
MaSp2. These proteins are described in U.S. Patent Numbers 7,521,228 and 5,989,894,
the entirety of which is herein incorporated by reference. In addition, the C-term is
present in various goat-derived spider silk proteins M4, M5 and M55 proteins, which are
described in U.S. Patent Application Publication No. 20010042255 A1, the entirety of
which is incorporated by reference in its entirety. In some embodiments, formic acid
and/or acetic acid may be included in as little as 0.3% (v/v) but even lower amounts
(0.1% v/v) are possible. Additionally, it is possible to solubilize rSSP without using any
additives.
Exemplary additives are set forth in Table 1 (below), where dope formulations
prepared according to the methods described herein and their resultant fibers/films
mechanical properties are listed in examples that follow.
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Table 1: Additives
1

Acid

2

3

4

Free Amino

Disulfide

5

Base

Other
Acids

Ammonium
Acetic

Reduction
β-

Arginine
Hydroxide

Triton X-100
mercaptoethanol

Sodium

Glutamic

Hydroxide

Acid

Formic

Dithiothreitol

Glutaraldahyde

Trifluoroacetic
Histidine

Calcium

Glycine

Potassium

acid
Other Organic
Acids
Other
Propionic Acid

Imidazole
Surfactants
Other Free
Other Ions
Amino Acids
L-DOPA

In some embodiments, aqueous spin dopes omit additives. In some
embodiments, the aqueous spin dope includes imidazole. In some embodiments, the
aqueous spin dope includes propionic acid.
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To formulate an aqueous solution of rSSP, additives can be chosen from any of
the 5 columns. For instance one or a combination of acids can be chosen from column 1
and combined with one or combinations of free amino acids from column 3, as well as
disulfide reducing compounds from column 4 and “Other” additives as required by the
particular protein. Generally, it would not be useful to include both an acid from
column 1 with a base from column 2. However, a base from column 2 can be combined
with additives from columns 3-4.
Sonication. In some embodiments, the mixture containing water, rSSP’s, and
optional additives may be sonicated. The addition of sonication to the rSSP and water
suspension may greatly increase the amount of solubilized protein. Sonication may be
performed with any suitable sonicator, such as a Misonix 3000 with microtip at 3.0
watts) either prior to microwaving, after microwaving and cooling, or both. Thus in
some embodiments, a solution formed containing water, rSSP’s, and optional additives
may be sonicated.
In embodiments, sonication may be employed to improve the amount of rSSP
solubilized and, thus, reduce the amount of protein required to form an aqueous spin
dope. Sonication also has the added benefit of producing a more homogenous solution.
Sonication also improves and/or changes mechanical properties for rSSP composition
products, particularly fiber mechanical properties.
For example, initial experiments required a 12.5% w/v MaSp1 analogue (125mg
MaSp1 into 1ml of aqueous) in order to spin a fiber. Sonicating after microwaving
reduced the concentration of MaSP1 to 5% w/v necessary to form fibers. Lower rSSP
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concentrations results in more fiber spun from a given amount of protein as well as finer
fibers which has been demonstrated to increase the mechanical properties in other
systems (electrospinning from HFIP based dope solutions).
Microwave Irradiation. The mixture containing water, rSSP’s, and optional
additives may be microwaved (or otherwise irradiated with microwave radiation) prior
to or after the optional sonication step. In embodiments, any microwave may be
employed. In some embodiments, the mixture should be sealed prior to microwaving so
as to avoid evaporation.
The mixture may be microwaved (irradiated with microwaves) for any suitable
amount of time to achieve the desired end product. The time depends on the power of
the microwave and the amount of solution to be microwaved. In some embodiments,
the solution may be stirred or agitated during microwaving so as to evenly expose the
mixture to the microwaves. Appropriate times per unit being microwaved include, for
example, from 10 to 90 seconds per 1 milliliter of mixture. In some embodiments the
1ml mixture may be set at from about 10-100% power for from about 5 to 120 seconds.
Without wishing to be bound to any particularly mechanism or theory, it is
believe that the irradiation of water and one or more rSSP’s increases the temperature
of the solution while concomitantly increasing the pressure on the constituents in
solution when irradiated or otherwise heated in a sealed vessel.
After microwaving, the solution is allowed to cool and/or is taken to other
processing steps, depending on the desired product.
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Centrifugation. In some embodiments, the microwaved (irradiated) mixture
may be optionally centrifuged. After centrifugation, the resulting supernatant may be
removed and then used for rSSP compositions and further processing.
Gel Formation. Hydrogels may be generated from aqueous rSSP solutions by
allowing the solubilized rSSP to cool. Additives to the dope such as acetic or formic acid
can delay the formation of the hydrogel to allow the rSSP to be transferred to a mold
prior to gelation. Theoretically, the variety of shapes that can be generated is limitless.
The additives to the solution will change the mechanical properties of the resulting
hydrogel. Hydrogel formation has been observed in solutions with as little as 3% w/v
rSSP:water and all iterations greater than that. The higher the % of rSSP, the more
rapidly the solution gelates. Work in other systems, Bombyx mori silk, has proven the
phenomenon that increasing the ratio of silk to water improves the mechanical
characteristics of the resulting hydrogel. As well, altering the temperature, pH and
including calcium ions changes the properties of the gels (Kim, UJ et al., 2004,
Biomacromolecules “Structure and Properties of Silk Hydrogels” Biomacromolecules 5,
786-792).
An example of a hydrogel application is illustrated in Chao et al., “Silk Hydrogel
for Cartilage Tissue Engineering.” Journal of Biomedical Materials Research Part B:
Applied Biomaterials, Vol 95B, Issue 1 pg 84-90, 2010.
Aerogels may be formed by freezing and then lyopholizing a solution or hydrogel
of rSSP. Theoretically, the shapes for these aerogels is also limitless as their starting
hydrogels could be allowed to form in a mold and then frozen and lyophilized.
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Film Formation. Films may be produced by pouring a dope solution onto a
substrate and allowing the water and other additives to evaporate. If it is desirable to
remove the film from the substrate, PDMS or Teflon allow the removal of the films. A
representative dope solution is: 50mg/ml MaSP1 analogue, 1% Formic Acid, 1% acetic
acid.
Films prepared by the techniques disclosed herein can vary in their dimensions.
An exemplary film size in working embodiments covers a 30 x 7 mm are when the rSSP
dope is poured. The film was then cut in half and the thick edges cut for a film with an
average length and width of 15 x 5.5 mm and an average thickness of 25um.
Resulting films can also be stretched in 50/50 isopropyl/water bath up to 3.5X.
Resulting films can also be stretched in 80/20 MeOH/water bath up to 3X.
Films may be applied as coatings or utilized after removal from a substrate.
Foam Formation. Foam may be generated from aqueous based solvents by a
variety of methods and dope conditions. One method reduced to practice is to
formulate a dope solution similar/identical to that described for film generation. That
solution is then placed into a vacuum chamber and a vacuum applied. The solution
quickly expands and forms a foam upon curing in the chamber. Additives to the dopes
such as surfactants will influence final cell size and further treatment of the foam
(alcohol) are possible to also change the final properties of the foams. It is also possible
that foams can be generated by chemical means, mainly peroxidase reactions, to
produce CO2 that creates bubbles in the dope and upon curing a foam remains. (See US
20110230911 A1 Scheibel). Again, this method is also influenced by additives such as
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surfactants and post formation treatments (alcohol). A final method is an extrusion
method whereby the dope solution is mechanically mixed with air, or other gas, to
produce foam. This method is also subject to additives and post formation treatments
to alter the final foam product.
Fiber Formation. Fibers can be spun from aqueous solutions of rSSP by extrusion
into a coagulation bath (alcohol) in a similar fashion as HFIP/aqueous based solutions of
rSSP as described in US Patent Application Publication No. 2005/0054830. To
summarize, the solubilized rSSP can be loaded into a syringe or other suitable extrusion
instrument and then pushed through a fine bore needle into a bath comprised of
isopropanol or other alcohol. As the rSSP drops through the alcohol, water is removed
and a fiber is formed. That fiber can then be taken up or processed further by stretching
in a second or even third bath comprised of alcohol(s), alcohol(s) and water or just
water. Fibers have been formed from solutions with as little as 5% w/v solutions of
rSSP:water. Similar 5% w/v solutions using HFIP as the solvent will not form fibers.
In some embodiments, it is unnecessary for the solution to remain liquid to form
fibers. Indeed, in some embodiments, fibers may be formed from a hydrogel. For
example, when forming fibers from MaSp2 proteins, the process may be stopped, the
syringe immediately removed for visualization, and a hydrogel may be observed. In
contrast, forming fibers from a hydrogel with MaSp1 proteins results in deleterious
effects.
It is important to note that each individual rSSP, due to its unique amino acid
sequence, will have different requirements for aqueous solubility. The rSSP

112

concentration, microwave time and power setting, amount of acid or base, and
requirements for free amino acids or surfactants will be different. There does not
appear to be one set of additives that achieves aqueous solubility and that also delays
hydrogel formation for all rSSP’s.
As an example, a 12.5% w/v solution of a MaSp1 and MaSp2 analogue can be
prepared identically in terms of additives. The MaSp1 will become soluble in water
easily and stay liquid for an extended period of time. The MaSp2, on the other hand,
will form a hydrogel within minutes of removal from the microwave and requires more
microwave time to solubilize.
The following examples are illustrative only and are not intended to limit the
disclosure in any way.
EXAMPLES
Process Example- Dope Preparation: An aqueous recombinant spider silk protein
(rSSP) dope solution was prepared by weighing out the rSSP such that a 1-40% (w/v) of
protein was achieved in 1 ml of water. For example, 50mg’s of protein in 1 ml of water
yielded a 5% w/v solution of protein to water. The suspension of rSSP and water was
sealed inside a 3ml glass Wheaton vial using a PTFE lined cap. The suspension and vial
were then placed in a conventional 1500 watt microwave and microwaved at 50%
power for 30 seconds. This solubilized the protein powder in the water.
Although this method may work to solubilize the rSSP, the solution quickly
formed a hydrogel upon cooling and was generally not available thereafter to spin fibers
by extrusion. If the goal of generating the aqueous dope is to form films, foams,
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hydrogels or aerogels, this method may be acceptable. Microwave time may vary
depending on the volume of the dope, rSSP used, additives chosen, and whether
sonication is utilized.
Process Example- Sonication: The following samples were prepared, one of
which was not sonicated:
(1) Dope Not Sonicated (12.5% M4, 1% acetic acid, 1% Formic Acid, 50mM L-Arg,
Microwaved 30” at 50% power, centrifuged at 6000 rpm for 3 minutes, 1.5X stretch, 40X
objective);
(2) Dope Sonicated (5% M4, 1% acetic acid, 1% formic acid, 50 mM L-Arg., microwaved
35 sec. at 50% power, sonicated at power level 1.5 (3 Watts) for 1.5 min., microwaved
30 sec. at 50% power, centrifuged 1 min. at 6000 rpm, 1.5X stretch, 40X objective.
Fibers spun from dopes that are not sonicated (Figure 1A), when analyzed
microscopically, appear to have numerous lumps and discontinuities. The sonicated 5%
w/v MaSP1 fibers (Figure 1B) appear much more uniform. Sonication has the added
benefit of requiring lower rSSP concentrations (5% compared to >8% without
sonication) to spin fibers from. Lower concentrations are advantageous as less protein
is used to spin similar lengths of fiber. Thus, fiber defects when spun from aqueous
dopes may be diminished by sonication of the dope.
The following examples set forth numerous rSSP sample tests and resulting data
according the formulations and processing criteria set forth below:
Example Set 1 125mg’s of M5 (Nephila clavipes MaSP2 analogue) was measured
out using a fine balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap.
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Included in the dope solution was 50uL of 1M L-arginine (L-Arginine is prepared in 18.2
MOhm water), 50uL of glacial acetic acid (5% v/v), and 900uL of 18.2 MOhm water. The
PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial were placed
into a conventional microwave (GE 1.6kW) and microwaved for 30 seconds at 50%
power. After microwaving, the solution was placed into a centrifuge (VWR Clinical 2000
set at 6,000 RPM) for 2 minutes to clarify. The supernatant is removed from any
remaining pellet for spinning fibers or producing other materials such as films, gels or
foams.
Fiber testing results (10 samples) for 1.5X post spin stretch in an 80:20
isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

37.25

0.75

60.05

0.02

St. Dev.

2.95

0.25

9.11

0.003

Fiber testing results (9 samples) for 2.0X post spin stretch in an 80:20
isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

37.40

1.98

52.94

0.047

St. Dev.

2.27

1.43

0.03
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Fiber testing results (9 samples) for 2.5X post spin stretch in an 80:20
isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

38.91

18.07

41.64

0.68

St. Dev.

5.15

14.64

17.17

0.54

Fiber testing results (10 samples) for 3.0X post spin stretch in an 80:20
isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

26.71

40.25

84.54

0.57

St. Dev.

2.12

14.27

18.04

0.18

Fiber testing results (10 samples) for 3.5X post spin stretch in an 80:20
isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

23.07

22.73

106.65

0.25

St. Dev.

2.64

8.76

22.91

0.09
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Example Set 2. 125mg’s of M5 (Nephila clavipes MaSP2 analogue) was
measured out using a fine balance into a 3ml Wheaton glass vial with PTFE seal inside a
plastic cap. Included in the dope solution was 50uL of 1M L-Arginine (L-Arginine is
prepared in 18.2 MOhm water), 100uL of glacial acetic acid (10% v/v), and 850uL of 18.2
MOhm water. The PTFE sealed cap was placed on the 3ml vial tightly. The solution and
vial were placed into a conventional microwave and microwaved for 30 seconds at 50%
power. After microwaving, the solution was placed into a centrifuge (VWR Clinical 2000
set at 6,000 RPM) for 2 minutes to clarify. The supernatant was removed from any
remaining pellet for spinning fibers or producing other materials such as films, gels or
foams.
Fiber testing results (9 samples) 1.5X post spin stretch in an 80:20
isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

34.17

4.52

72.88

0.07

St. Dev.

5.74

3.10

13.83

0.05
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Fiber testing results (9 samples) 2.0X post spin stretch in an 80:20
isopropanol:water bath.

Diameter (µm)

Energy to Break

Max Stress

Max Strain

(MJ/m3)

(MPa)

(mm/mm)

Average

31.02

3.92

74.05

0.08

St. Dev.

5.03

2.56

20.69

0.06

Fiber testing results (10 samples) 2.5X post spin stretch in an 80:20
isopropanol:water bath.
Diameter (µm)

Energy to Break

Max Stress

Max Strain

(MJ/m3)

(MPa)

(mm/mm)

Average

25.95

15.34

102.62

0.19

St. Dev.

1.08

13.71

17.87

0.18

Fiber testing results (10 samples) 3.0X post spin stretch in an 80:20
isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

25.71

41.89

87.67

0.55

St. Dev.

2.46

26.92

18.06

0.30
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Example Set 3 125mg’s of M5 (Nephila clavipes MaSP2 analogue) was measured
out using a fine balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 50uL of 1M L-Arginine (L-Arginine is prepared in 18.2
MOhm water), 150uL of glacial acetic acid (15% v/v), and 800uL of 18.2 MOhm water.
The PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial were
placed into a conventional microwave and microwaved for 30 seconds at 50% power.
After microwaving, the solution was placed into a centrifuge (VWR Clinical 2000 set at
6,000 RPM) for 2 minutes to clarify. The supernatant was removed from any remaining
pellet for spinning fibers or producing other materials such as films, gels or foams.
Fiber testing results (10 samples) 1.5X post spin stretch in an 80:20
isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

39.20

3.77

69.92

0.07

St. Dev.

10.74

3.66

15.36

0.06

Fiber testing results (10 samples) 2.0X post spin stretch in an 80:20
isopropanol:water bath.
Diameter (µm)

Energy to Break

Max Stress

Max Strain

(MJ/m3)

(MPa)

(mm/mm)

Average

46.93

20.47

53.81

0.37

St. Dev.

5.23

23.18

14.17

0.35
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Fiber testing results (10 samples) 2.5X post spin stretch in an 80:20
isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

46.05

24.95

52.00

0.49

St. Dev.

6.42

25.25

16.49

0.43

Example Set 4. 125mg’s of M5 (Nephila clavipes MaSP2 analogue) was measured
out using a fine balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 50uL of 1M L-Arginine (L-Arginine is prepared in 18.2
MOhm water), 200uL of glacial acetic acid (20% v/v), and 750uL of 18.2 MOhm water.
The PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial were
placed into a conventional microwave and microwaved for 30 seconds at 50% power.
After microwaving, the solution was placed into a centrifuge (VWR Clinical 2000 set at
6,000 RPM) for 2 minutes to clarify. The supernatant was removed from any remaining
pellet for spinning fibers or producing other materials such as films, gels or foams.
Fiber testing results (10 samples) 1.5X post spin stretch in an 80:20
isopropanol:water bath.
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Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

46.38

0.26

33.18

0.014

St. Dev.

10.11

0.11

7.64

0.003

Fiber testing results (9 samples) 2.0X post spin stretch in an 80:20
isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

44.65

1.09

63.71

0.02

St. Dev.

8.29

1.39

32.07

0.009

Fiber testing results (10 samples) 3.5X post spin stretch in an 80:20
isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

37.44

8.44

80.85

0.13

St. Dev.

2.04

11.70

8.09

0.16
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Example Set 5. 125mg’s of M4 (Nephila clavipes MaSP1 analogue) was measured
out using a fine balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 50uL of 1M L-Arginine (L-Arginine is prepared in 18.2
MOhm water), 10uL of glacial acetic acid (1% v/v), 10uL of 88% Formic Acid (1% v/v),
830uL of 18.2 MOhm water. The PTFE sealed cap was placed on the 3ml vial tightly. The
solution and vial were placed into a conventional microwave and microwaved for 30
seconds at 50% power. After microwaving, the solution was placed into a centrifuge for
5 minutes to clarify. The supernatant was removed from any remaining pellet for
spinning fibers or producing other materials such as films, gels or foams.
Fiber testing results (10 samples) 1.5X post spin stretch in an 80:20
isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

43.25

2.25

31.68

0.08

St. Dev.

16.23

1.25

7.83

0.04

Fiber testing results (10 samples) 2.0X post spin stretch in an 80:20
isopropanol:water bath.
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Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

30.02

5.02

61.68

0.09

St. Dev.

2.71

4.79

15.99

0.07

Fiber testing results (10 samples) 2.5X post spin stretch in an 80:20
isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

28.44

20.93

73.15

0.30

St. Dev.

3.40

18.50

30.78

0.16

Fiber testing results (9 samples) 3.0X post spin stretch in an 80:20
isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

27.57

3.85

33.38

0.14

St. Dev.

3.88

3.49

21.80

0.08
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Example Set 6. 125mg’s of M4 (Nephila clavipes MaSP1 analogue) was measured
out using a fine balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 50uL of 1M L-Arginine (L-Arginine is prepared in 18.2
MOhm water), 10uL of glacial acetic acid (1% v/v), 30uL of 88% Formic Acid (3% v/v),
and 810uL of 18.2 MOhm water. The PTFE sealed cap was placed on the 3ml vial tightly.
The solution and vial were placed into a conventional microwave and microwaved for 30
seconds. The solution and vial were allowed to cool and then, the solution was
sonicated using a microtip on a Misonix sonicator for 1 minute at a power setting of 1.5.
The PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial were
placed into a conventional microwave and microwaved for 30 seconds at 50% power.
After microwaving, the solution was placed into a centrifuge for 5 minutes to clarify.
The supernatant was removed from any remaining pellet for spinning fibers or
producing other materials such as films, gels or foams.
Fiber testing results (8 samples) 1.5X post spin stretch in an 80:20
isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

37.05

0.44

58.36

0.01

St. Dev.

3.32

0.14

13.03

0.002
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Fiber testing results (9 samples) 2.0X post spin stretch in an 80:20
isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

49.03

0.51

33.61

0.02

St. Dev.

2.45

0.16

3.24

0.006

Fiber testing results (10 samples) 2.5X post spin stretch in an 80:20
isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

39.26

2.43

65.19

0.05

St. Dev.

10.08

1.96

35.24

0.04

Fiber testing results (10 samples) 3.0X post spin stretch in an 80:20
isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

26.42

1.12

98.28

0.02

St. Dev.

2.27

0.19

13.89

0.002
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Example Set 7. 50mg’s (5% w/v) of M4 (Nephila clavipes MaSP1 analogue) was
measured out using a fine balance into a 3ml Wheaton glass vial with PTFE seal inside a
plastic cap. Included in the dope solution was 50uL of 1M L-Arginine (L-Arginine is
prepared in 18.2 MOhm water), 10uL of glacial acetic acid (1% v/v), and 940uL of 18.2
MOhm water. The PTFE sealed cap was placed on the 3ml vial tightly. The solution and
vial were placed into a conventional microwave and microwaved for 30 seconds at 50%
power. After microwaving and cooling for 5 minutes, the solution was sonicated for 1
minute at 3.0 watts. After microwaving, the solution was placed into a centrifuge for 2
minutes to clarify. The supernatant was removed from any remaining pellet for spinning
fibers or producing other materials such as films, gels or foams.
Fiber testing results 1.5X post spin stretch in an 80:20 isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

26.35

0.74

59.87

0.02

St. Dev.

0.35

0.39

8.30

0.007

Fiber testing results 3.0X post spin stretch in an 80:20 isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

17.30

16.31

112.10

0.16

St. Dev.

1.15

12.92

16.81

0.12
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Example Set 8. 80mg’s (8% w/v) of M4 (Nephila clavipes MaSP1 analogue) in
addition to 20mg’s (2% w/v) of M5(Nephila clavipes MaSP2 analogue) was measured out
using a fine balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 50uL of 1M L-Arginine (L-Arginine is prepared in 18.2
MOhm water), 50uL of glacial acetic acid (5% v/v), and 940uL of 18.2 MOhm water. The
PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial were placed
into a conventional microwave and microwaved for 35 seconds at 50% power. After
microwaving, the solution was placed into a centrifuge for 3 minutes to clarify. The
supernatant was removed from any remaining pellet for spinning fibers or producing
other materials such as films, gels or foams
Fiber testing results 2.0X post spin stretch in an 80:20 isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

31.62

1.70

68.16

0.04

St. Dev.

5.59

0.42

14.59

0.003

Fiber testing results 2.5X post spin stretch in an 80:20 isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

29.05

10.63

80.98

0.16

St. Dev.

1.07

3.84

10.78

0.04
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Fiber testing results 3.0X post spin stretch in an 80:20 isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

25.48

23.31

84.91

0.31

St. Dev.

1.85

17.46

6.96

0.23

Fiber testing results 3.5X post spin stretch in an 80:20 isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

27.60

14.92

79.61

0.21

St. Dev.

3.88

10.83

37.40

0.13

Example Set 9. 62.5mg’s of M4 (Nephila clavipes MaSP1 analogue) and 62.5
mg’s of M5 (Nephila clavipes MaSP2 analogue) was measured out using a fine balance
into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap. Included in the dope
solution was18.2 MOhm water. The PTFE sealed cap was placed on the 3ml vial tightly.
The solution and vial were placed into a conventional microwave and microwaved for 5
seconds repetitively with mixing between bursts of microwave 5 total times. The
solution and vial were allowed to cool and then, the solution was sonicated using a
microtip on a Misonix sonicator for 1 minute at a power setting of 1.5. The PTFE sealed
cap was placed on the 3ml vial tightly. After microwaving, the solution was placed into a
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centrifuge for 5 minutes to clarify. The supernatant was removed from any remaining
pellet for spinning fibers or producing other materials such as films, gels or foams.
Fiber testing results for a dual stretch; 2X then 1.5X post spin stretch in an 80:20
isopropanol:water and then 20:80 isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

54.94

16.15

43.14

0.44

St. Dev.

2.55

7.88

4.87

Fiber testing results for a dual stretch; 1.5X then 2.0X post spin stretch in an
80:20 isopropanol:water and then 20:80 isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

45.41

8.12

54.24

0.17

St. Dev.

7.43

9.28

16.69

0.18

112.5mg’s of M4 (Nephila clavipes MaSP1 analogue) and 12.5 mg’s of M5
(Nephila clavipes MaSP2 analogue) was measured out using a fine balance into a 3ml
Wheaton glass vial with PTFE seal inside a plastic cap. Included in the dope solution
was18.2 MOhm water, 0.1% v/v propionic acid, and 10mM imidazole. The PTFE sealed
cap was placed on the 3ml vial tightly. The solution and vial were placed into a
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conventional microwave and microwaved for 5 seconds repetitively with mixing
between bursts of microwave 5 total times. The solution and vial were allowed to cool
and then, the solution was sonicated using a microtip on a Misonix sonicator for 1
minute at a power setting of 1.5. The PTFE sealed cap was placed on the 3ml vial tightly.
After microwaving, the solution was placed into a centrifuge for 5 minutes to clarify.
The supernatant was removed from any remaining pellet for spinning fibers or
producing other materials such as films, gels or foams.
Fiber testing results for a dual stretch; 2.0X then 2.5X post spin stretch in an
80:20 isopropanol:water and then 20:80 isopropanol:water bath.
Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

37.29

33.77

134.50

0.28

St. Dev.

2.64

33.55

38.78

0.26

Fiber testing results for a dual stretch; 2.5X then 2.0X post spin stretch in an
80:20 isopropanol:water and then 20:80 isopropanol:water bath.

Diameter

Energy to Break

Max Stress

Max Strain

(µm)

(MJ/m3)

(MPa)

(mm/mm)

Average

36.98

28.52

192.22

0.18

St. Dev.

3.84

11.97

51.74

0.04
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Adhesives. 50mg’s of M4 (Nephila clavipes MaSP1 analogue) was measured out
using a fine balance into a 3ml Wheaton glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 1000µL of 18.2 MOhm water. The PTFE sealed cap
was placed on the 3ml vial tightly. The solution and vial were placed into a conventional
microwave and microwaved for 55 seconds. 80µl of solubilized M4 was removed from
the vial and pipette onto an acrylic plastic plate and assembled with a second plate as in
Figure 2. Half of the tested assemblies were scored plastic while the second half was
unscored, smooth plastic. Gluing boards were heated in an oven to dry for 24 hours at
30°C. Samples were then tested with a mechanical testing frame (MTS) as shown in
Figure 2 with Max Stress and Max Strain observations as reported in Table 2.
Table 2.
Max Stress (Mpa)

Max Strain (mm/mm)

Scored 0

0.240553633

0.061867451

Scored 1

0.284113645

0.050748235

Scored 2

0.290257593

0.032738039

Scored 3

0.207217517

0.053287059

Scored 4

0.275858824

0.038258039

Scored 5

0.23692426

0.035489412

Average

0.255820912

0.045398039

131

Max Stress (Mpa)

Max Strain (mm/mm)

Unscored 1

0.045467462

0.018403922

Unscored 2

0.087084871

0.039007059

Unscored 3

0.108057714

0.051941961

Unscored 4

0.115011765

0.027708235

Unscored 6

0.152559701

0.064506667

Average

0.101636302

0.040313569

25mg’s of M4 (Nephila clavipes MaSP1 analogue) and 25mg’s of M5 (Nephila
clavipes MaSP2 analogue) was measured out using a fine balance into a 3ml Wheaton
glass vial with PTFE seal inside a plastic cap. Included in the dope solution was 1000µL
of 18.2 MOhm water. The PTFE sealed cap was placed on the 3ml vial tightly. The
solution and vial were placed into a conventional microwave and microwaved for 55
seconds. 80µl of solubilized M4 and M5 was removed to a plastic plate and assembled
with a second plate as in Figure 1. Half of the tested assemblies were scored plastic
while the second half was unscored, smooth plastic. Gluing boards were heated in an
oven to dry for 24 hours at 30°C. Samples were then tested with a mechanical testing
frame (MTS) as represented in Figure 2 with Max Stress and Max Strain observations as
reported in Table 3.
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Table 3.
Max Stress (Mpa)

Max Strain (mm/mm)

Scored 0

0.405474817

0.059890196

Scored 1

0.355278111

0.051212549

Scored 2

0.509896194

0.055307451

Scored 3

0.35507744

0.064501176

Scored 4

0.300653595

0.038214902

Scored 5

0.406243752

0.052461176

Average

0.388770652

0.053597908

Unscored 1

0.267291844

0.049407843

Unscored 2

0.336299834

0.05244549

Unscored 3

0.287887532

0.04240549

Unscored 4

0.341145098

0.051715294

Unscored 6

0.336461433

0.038015686

Average

0.313817148

0.046797961

40mg’s of M4 (Nephila clavipes MaSP1 analogue) and 10mg’s of M5 (Nephila
clavipes MaSP2 analogue) was measured out using a fine balance into a 3ml Wheaton
glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 1000µL of 18.2 MOhm water. The PTFE sealed
cap was placed on the 3ml vial tightly. The solution and vial were placed into a
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conventional microwave and microwaved for 55 seconds. 80µl of solubilized M4 and
M5 was removed to a plastic plate and assembled with a second plate as in Figure 1.
Half of the tested assemblies were scored plastic while the second half was unscored,
smooth plastic. Gluing boards were heated in an oven to dry for 24 hours at 30°C.
Samples were then tested with a mechanical testing frame (MTS) as represented in
Figure 2 with Max Stress and Max Strain observations as reported in Table 4.
Table 4.
Max Stress Mpa

Max Strain
(mm/mm)

Scored 0

0.297577855

0.043788235

Scored 1

0318335334

0.048578824

Scored 2

0.480984237

0.074135686

Scored 3

0.299748226

0.053203922

Scored 4

0.360972549

0.049265882

Scored 5

0.372502884

0.041647843

Average

0.355020181

0.051770065

Unscored 1

0.123302074

0.019305882

Unscored 2

0.185370089

0.037901961

Unscored 3

0.107880133

0.025557647

Unscored 4

0.184345098

0.031705882
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Max Stress Mpa

Max Strain
(mm/mm)

Unscored 6

0.167574578

0.031900392

Average

0.153694395

0.029274353

32.5mg’s of M4 (Nephila clavipes MaSP1 analogue) and 17.5mg’s of M5 (Nephila
clavipes MaSP2 analogue) was measured out using a fine balance into a 3ml Wheaton
glass vial with PTFE seal inside a plastic cap. Included in the dope solution was 1000µL
of 18.2 MOhm water. The PTFE sealed cap was placed on the 3ml vial tightly. The
solution and vial were placed into a conventional microwave and microwaved for 90
seconds. 80µl of solubilized M4 and M5 was removed to a plastic plate and assembled
with a second plate as in Figure 1. Half of the tested assemblies were scored plastic
while the second half was unscored, smooth plastic. Gluing boards were heated in an
oven to dry for 24 hours at 30°C. Samples were then tested with a mechanical testing
frame (MTS) as represented in Figure 2 with Max Stress and Max Strain observations as
reported in Table 5.
Table 5.
Max Stress (Mpa)

Max Strain (mm/mm)

Scored 0

0.355832372

0.048123137

Scored 1

0.248919646

0.039603137

Scored 2

0.516693579

0.078197647
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Max Stress (Mpa)

Max Strain (mm/mm)

Scored 3

0.298771649

0.043566275

Scored 4

0.230065359

0.033040784

Scored 5

0.279468109

0.031095686

Average

0.321625119

0.045604444

Unscored 1

0.114691674

0.024512157

Unscored 2

0.21934737

0.040428235

Unscored 3

0.212504624

0.038014118

Unscored 6

0.232669566

0.037479216

Average

0.194803309

0.035108431

32.5mg’s of M4 (Nephila clavipes MaSP1 analogue) and 17.5mg’s of M5 (Nephila
clavipes MaSP2 analogue) was measured out using a fine balance into a 3ml Wheaton
glass vial with PTFE seal inside a plastic cap. Included in the dope solution was 1000µL
of 18.2 MOhm water. The PTFE sealed cap was placed on the 3ml vial tightly. The
solution and vial were placed into a conventional microwave and microwaved for 90
seconds. 80µl of solubilized M4 and M5 was removed to a plastic plate and assembled
with a second plate as in Figure 1. Half of the tested assemblies were scored plastic
while the second half was unscored, smooth plastic. Gluing boards were heated in an
oven to dry for 24 hours at 30°C. Samples were then tested with a mechanical testing
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frame (MTS) as represented in Figure 2 with Max Stress and Max Strain observations as
reported in Table 6.
Table 6.
Max Stress (Mpa)

Max Strain (mm/mm)

Scored 0

0.339623222

0.043734118

Scored 1

0.323233293

0.040177255

Scored 2

0.533025759

0.05397098

Scored 3

0.307164111

0.03688

Scored 4

0.29905421

0.041872941

Scored 5

0.348283375

0.035167843

Average

0.358397328

0.04196719

Unscored 1

0.083830634

0.022381961

Unscored 2

0.141176471

0.034233725

Unscored 3

0.107584166

0.029144314

Unscored 4

0.184094118

0.047931765

Unscored 6

0.149996185

0.021408627

Average

0.133336315

0.031020078

40mg’s of M4 (Nephila clavipes MaSP1 analogue) and 10mg’s of M5 (Nephila
clavipes MaSP2 analogue) was measured out using a fine balance into a 3ml Wheaton
glass vial with PTFE seal inside a plastic cap. Included in the dope solution was 900µL of
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18.2 MOhm water, 100µl 1M imidazole [10mM imidazole], and 1µl propionic acid (99%).
The PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial were
placed into a conventional microwave and microwaved for 57 seconds. 80µl of
solubilized M4 and M5 was removed to a plastic plate and assembled with a second
plate as in Figure 1. Half of the tested assemblies were scored plastic while the second
half was unscored, smooth plastic. Gluing boards were heated in an oven to dry for 24
hours at 30°C. Samples were then tested with a mechanical testing frame (MTS) as
represented in Figure 2 with Max Stress and Max Strain observations as reported in
Table 7.
Table 7
Max Stress (Mpa)

Max Strain (mm/mm)

Scored 0

0.191741638

0.028792941

Scored 1

0.201488595

0.034137255

Scored 2

0.300499808

0.057567843

Scored 3

0.198794537

0.039624314

Scored 5

0.322301061

0.048321569

Average

0.242965128

0.041688784

Unscored 1

0.097300369

0.026557647

Unscored 2

0.064799942

0.024059608

Unscored 3

0.074110248

0.02491451
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Max Stress (Mpa)

Max Strain (mm/mm)

Unscored 4

0.038901961

0.006124706

Unscored 6

0.171053635

0.032146667

Average

0.089233231

0.022760627

25mg’s of M4 (Nephila clavipes MaSP1 analogue) and 25mg’s of M5 (Nephila
clavipes MaSP2 analogue) was measured out using a fine balance into a 3ml Wheaton
glass vial with PTFE seal inside a plastic cap. Included in the dope solution was 900µL of
18.2 MOhm water, 100µl 1M imidazole [10mM imidazole], and 1µl propionic acid (99%).
The PTFE sealed cap was placed on the 3ml vial tightly. The suspension was sonicated
for 1 minute at 3 watts using a microtip on a misonix 3000 sonicator. The solution and
vial were placed into a conventional microwave and microwaved for 57 seconds. The
solution was clarified by centrifugation at 18kG for one minute. 80µl of solubilized M4
and M5 was removed to a plastic plate and assembled with a second plate as in Figure
1. Half of the tested assemblies were scored plastic while the second half was unscored,
smooth plastic. Gluing boards were heated in an oven to dry for 24 hours at 30°C.
Samples were then tested with a mechanical testing frame (MTS) as represented in
Figure 2 with Max Stress and Max Strain observations as reported in Table 8.
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Table 8.
Max Stress (Mpa)

Max Strain (mm/mm)

Scored 0

0.308066128

0.032904314

Scored 1

0.310748299

0.038625882

Scored 2

0.408981161

0.066913725

Scored 4

0.291878897

0.048646275

Scored 5

0.347314578

0.046457255

Average

0.333397813

0.04670949

Unscored 1

0.082512119

0.022306667

Unscored 2

0.120281169

0.029595294

Unscored 3

0.173145098

0.034516078

Unscored 4

0.163302052

0.040027451

Unscored 6

0.184390619

0.036623529

Average

0.144726212

0.032613804

Silicon Adhesive. 180mg’s of M4 (Nephila clavipes MaSP1 analogue) and
180mg’s of M5 (Nephila clavipes MaSP2 analogue) was measured out using a fine
balance into a 8ml Wheaton glass vial with PTFE seal inside a plastic cap. Included in the
dope solution was 2640µL of 18.2 MOhm water, 30µl L-Dopa [stock concentration =
10mg/ml], 30µl propionic acid (99%), 300µl of imidazole [stock concentration =
100mM]. The PTFE sealed cap was placed on the 3ml vial tightly. The suspension was
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sonicated for 1 minute at 3 watts using a microtip on a misonix 3000 sonicator. The
solution and vial were placed into a conventional microwave and microwaved in 5
second burst until solubilized with mixing by swirling between bursts. The solution was
clarified by centrifugation at 18kG for one minute. Solubilized protein is then
transferred to an air sprayer bowl (Master Airbrush® Brand Model VC16-B22). Air
pressure is applied and a fine mist is produced. The mist is then coated onto each
silicon surface to be adhered 3 times with a 3 minute dry period between coats.
A second dope is prepared as described in the first paragraph under the heading
“Silicon Adhesive” as the bulk adhesive. Approximately 100µl of that solution is then
placed on top of one half of the coated silicon. The two pieces of silicon were then
gently pressed together and placed into a drying oven preheated to 30°C. Adhesives
were cured for 24 hours in the oven. Mechanical testing was performed on a MTS
Synergy 100 by placing the ends of each piece of silicon in clamping grips and pulling on
the ends until the bond failed.

Energy to Break
Adhesive

Max Stress (MPa)

Max Strain (mm/mm)

(MJ/m3)

Super Glue

0.0495

0.2099

0.0064

Elmers

0.0196

0.0612

0.0007

Spider Silk

0.0292

0.0819

0.0014
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Foams. 144mg’s of M4 (Nephila clavipes MaSP1 analogue) and 36mg’s of M5
(Nephila clavipes MaSP2 analogue) was measured out using a fine balance into a 8ml
Wheaton glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 2640µL of 18.2 MOhm water, 30µl L-Dopa
[stock concentration = 10mg/ml], 30µl propionic acid (99%), and 300µl of imidazole
[stock concentration = 1M]. The PTFE sealed cap was placed on the 3ml vial tightly. The
suspension was sonicated for 1 minute at 3 watts using a microtip on a misonix 3000
sonicator. The solution and vial were placed into a conventional microwave and
microwaved in 5 second burst until solubilized with mixing by swirling between bursts.
The solution was clarified by centrifugation at 18kG for one minute. The solubilized
protein was then placed on a glass slide and aspirated with a glass pipette until air
bubbles were dispersed throughout the solution and allowed to dry on the bench. After
a several hours of drying, a spongy foam remained on the glass slide.
Hydrogels. 60mg’s of M4 (Nephila clavipes MaSP1 analogue) and 60mg’s of M5
(Nephila clavipes MaSP2 analogue) was measured out using a fine balance into an 8ml
Wheaton glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 1960µL of 18.2 MOhm water and 40µl
propionic acid (99%). The PTFE sealed cap was placed on the 3ml vial tightly. The
solution and vial were placed into a conventional microwave and microwaved in 5
second burst, 6 times with mixing by swirling between. The suspension was sonicated
for 1 minute at 3 watts using a microtip on a misonix 3000 sonicator. After 1 minute of
cooling, the lid was removed and the solution poured into a circular plastic mold. The
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mold is sealed on the bottom with sheet silicon to prevent the solution from leaking out
of the mold. The mold can be of any dimension or shape. The solution remains in the
mold until hydrogel formation and then removed by pushing the hydrogel from the
mold.
60mg’s of M4 (Nephila clavipes MaSP1 analogue) and 60mg’s of M5 (Nephila
clavipes MaSP2 analogue) was measured out using a fine balance into an 8ml Wheaton
glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 1960µL of 18.2 MOhm water and 60µl
propionic acid (99%).
The PTFE sealed cap was placed on the 3ml vial tightly. The solution and vial
were placed into a conventional microwave and microwaved in 5 second burst, 6 times
with mixing by swirling between. The suspension was sonicated for 1 minute at 3 watts
using a microtip on a misonix 3000 sonicator. After 1 minute of cooling, the lid was
removed and the solution poured into a circular plastic mold. The mold is sealed on the
bottom with sheet silicon to prevent the solution from leaking out of the mold. The
mold can be of any dimension or shape. The solution remains in the mold until hydrogel
formation and then removed by pushing the hydrogel from the mold.
Hydrogels were treated with various alcohols after formation by submerging the
hydrogel in their respective solution for 60 minutes, then a water rinse for 60 minutes
and their mechanical properties studied. They are reported in Table 9.
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Table 9.
Post-

Max Stress

Max Strain

Elastic Modulus

Treatment

(MPa)

(mm/mm)

(MPa)

H20

0.01727

0.222752

0.078356

50/50 MeOH

0.027454

0.201667

0.175385

50/50 IPA

0.033131

0.250283

0.165239

50/50 EtOH

0.033621

0.175943

0.228684

Hysteresis testing of hydrogels demonstrates that the gels produced are elastic
and able to survive repeated loadings. Hydrogels were of the same formulation as
reported in the first two paragraphs under heading “hydrogels” above. Results of
testing hydrogels is shown in Figure 3 as well as Table 10.
Table 10.
Specimen (No.)

Specimen Height (mm)

Peak Load for Entire Test (N)

1

10.3

2.546

2

10.7

2.5

3

10.8

1.603

4

11

2.921

Lyogels. Lyogels are prepared from hydrogels prepared as reported. Once a
hydrogel is formed, that gel is placed into a lyopholization chamber and dried under
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vacuum until water is removed leaving only the protein behind. The lyogels can then be
post treated to alter the mechanical properties of the lyogel.
60mg’s of M4 (Nephila clavipes MaSP1 analogue) and 60mg’s of M5 (Nephila
clavipes MaSP2 analogue) was measured out using a fine balance into an 8ml Wheaton
glass vial with PTFE seal inside a plastic cap. Included in the dope solution was 1960µL
of 18.2 MOhm water and 40µl propionic acid (99%). The PTFE sealed cap was placed on
the 3ml vial tightly. The solution and vial were placed into a conventional microwave
and microwaved in 5 second burst, 6 times with mixing by swirling between. The
suspension was sonicated for 1 minute at 3 watts using a microtip on a misonix 3000
sonicator. After 1 minute of cooling, the lid was removed and the solution poured into a
circular plastic mold. The mold is sealed on the bottom with sheet silicon to prevent the
solution from leaking out of the mold. The mold can be of any dimension or shape. The
solution remains in the mold until hydrogel formation and then removed by pushing the
hydrogel from the mold. Once the hydrogel was formed and removed from the mold, it
was frozen and placed into a lyopholization bell. Vacuum was applied for 12 hours.
Once dried, the lyogels were removed from the lyopholizer and treated with one of
three alcohol solutions (50/50 water/isopropanol, 50/50 water/ethanol, 50/50
methanol) or water as a control and then mechanically tested by compressing them
while measuring stress and strain as shown in Table 11.
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Table 11.
Post

Max Strain

Elastic Modulus

(mm/mm)

(MPa)

Max Stress (MPa)
Treatment
H20

0.93

0.76

1.00

50/50 IPA

0.14

0.37

0.47

50/50 EtOH

0.04

0.14

0.38

50/50 MeOH

0.09

0.28

0.33

Coatings. 90mg’s of M4 (Nephila clavipes MaSP1 analogue) and 90mg’s of M5
(Nephila clavipes MaSP2 analogue) was measured out using a fine balance into an 8ml
Wheaton glass vial with PTFE seal inside a plastic cap. Included in the dope solution was
2930µl of 18.2 MOhm water, 10mM imidazole, 30µl propionic acid (99%), and 30µl LDopa (30ug L-Dopa). The suspension was sonicated for 1 minute at 3 watts using a
microtip on a misonix 3000 sonicator. The PTFE sealed cap was placed on the 3ml vial
tightly. The solution and vial were placed into a conventional microwave and
microwaved in 5 second burst, 6 times with mixing by swirling between. After 1 minute
of cooling, the lid was removed and the solution removed to a either a dip bath or
sprayer.
Dip coats were achieved by dipping samples repeatedly in the dope solution or
dragging through a bath of spider silk protein. The samples are then dried completely
on the bench. Dip coatings can be reapplied until the desired thickness is achieved.
Spray coatings were achieved by removing the soluble silk protein to a Master
Airbrush Model G233 with a 0.2mm needle tip and spraying the solution onto the
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substrate. Spray coatings can be reapplied until the desired thickness of coating is
achieved.
Spray and dip coatings can be combined as well. It was observed that a light
spray coating, after drying, then dip coating produced a visually impressive coating and
it also appeared to adhere to the substrate to a greater degree.
Silicon wafers were coated with aqueous based recombinant spider silk proteins
via the spraying method described in the first two paragraphs under the heading “Silicon
Adhesives”. Antibiotics and other substances were included in the dope solutions to
functionalize the coating. (Kanamycin at 10µg/wafer). Coatings were submerged in
Congo Red dye (β-sheet specific dye) to allow visualization of the coating without the
aid of a microscope.
All solutions were prepared as dip coats described in the second paragraph
following the heading “Coatings.” Resulting products are shown in Figure 4.
Silicon urinary catheters (3 french) coated with spider silk protein (top), spider
silk coating loaded with 50mg/L kanamycin (middle) and spider silk coating loaded with
500mg/L kanamycin (bottom) as shown in Figure 5.
Stainless steel can also be coated using dope solutions prepared as described in
the second paragraph following the heading “Coatings.” Both spray and dip coating can
be used to coat surgical stainless steel.
A stainless steel plate was dip coated with recombinant spider silk protein.
Congo Red dye (stains β-sheets) was used to visualize the coating as shown in Figure 6.
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Capsules. Capsules can be generated from the described aqueous methods by
solvating the recombinant spider silk proteins in water and then allowing them to
precipitate or by driving their precipitation via salt precipitation. When combined with
another substance, such as a vaccine, the spider silk proteins encapsulate the vaccine.
Alternative Solvation Method : Autoclave. An alternative method of solvation was
also tested successfully. Rather than using a microwave to irradiate an aqueous dope,
heat and pressure inside of a sealed vial was performed using an autoclave.
60mg’s of M4 (Nephila clavipes MaSP1 analogue) and 60mg’s of M5 (Nephila
clavipes MaSP2 analogue) was measured out using a fine balance into an 8ml Wheaton
glass vial with PTFE seal inside a plastic cap.
Included in the dope solution was 1960µL of 18.2 MOhm water and 40µl
propionic acid (99%). The PTFE sealed cap was placed on the 3ml vial tightly. The
solution and vial were placed into a conventional microwave and microwaved in 5
second burst, 6 times with mixing by swirling between. The suspension was sonicated
for 1 minute at 3 watts using a microtip on a misonix 3000 sonicator. After 1 minute of
cooling, the lid was removed and the solution poured into a circular plastic mold. The
mold is sealed on the bottom with sheet silicon to prevent the solution from leaking out
of the mold. The mold can be of any dimension or shape. The solution remains in the
mold until hydrogel formation and then removed by pushing the hydrogel from the
mold.
The vial was placed it an autoclave for 75 minutes at 123°C and 20.1 PSI with the
lid on, but not tightened. Immediately after removal from the autoclave and cooling,
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the solution turned to a hydrogel even though not all of the protein was solvated (visual
inspection of white precipitate in vial). However, the method did work to solvate the
protein as indicated by the formation of a hydrogel.
The autoclave experiment demonstrates that microwave irradiation
unexpectantly provides conditions for aqueous solvation of rSSP. Without wishing to be
bound to any particular theory, the source of temperature and pressue from microwave
irradiation may be uniquely suited for solvation of the proteins. Microwave irradiation
is convenient as it develops heat and temperature quickly within the vial while an
autoclave took 75 minutes to only partially solubilize available protein. Other methods
of generating heat and pressure are available that generate higher pressure and
temperature without the use of a microwave that could be used to solubilize the
proteins.
The methods and compositions described herein may also be applied to other
traditionally insoluble proteins. Exemplary proteins that may be used in these methods
include naturally occurring and synthetic proteins associated with protein misfolding
diseases such as prions (CWD, BSE, vBSE, Creutzfeldt-Jakob), Alzheimers, and
Parkinsons.
Additionally, synthetically produced G-protein couple receptors (GPCR) are
difficult targets as they to suffer aqueous solubility issues. Approximately 40% of drugs
produced today are targeted at GPCR’s. The methods described herein may also be
applied to such GPCR’s.
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In addition, numerous proteins when expressed in E.coli, are recovered as
inclusion bodies. Inclusion bodies are aggregates of the expressed protein that are also
insoluble in aqueous solutions. In order to solubilize these proteins, generally high
concentrations of urea are used to denature the protein(s). Once denatured, the
proteins then have to be renatured into their correct conformation for them to have
biological activity. That is not an easy, cheap or quick means by which to synthetically
produce proteins. The methods and compositions described herein may also address
such insolubility issues with such proteins associated with inclusion bodies.
Statements
1.

A method of solubilizing one or more recombinant spider silk proteins in

an aqueous solution, comprising:
mixing the one or more recombinant spider silk proteins with water to
form a mixture in a sealed container;
heating the mixture to form a solution.
2.

The method of claim 1, wherein the heating is performed with microwave

irradiation.
3.

The method of any one of claims 1-2, further comprising sonicating the

mixture.
4.

The method of any one of claims 1-3, further comprising sonicating the

solution.
5.

The method of any one of claims 1-4, further comprising centrifuging the

solution.
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6.

The method of any one of claims 1-5, further comprising providing

additives for reducing gel formation in the solution.
7.

The method of claim 6, wherein the additives are selected from the group

consisting of: an acid, a base, free amino acids, surfactants, and combinations
thereof.
8.

The method of claim 6, wherein the additives are selected from the group

consisting of: propionic acid, formic acid, acetic acid, ammonium hydroxide, Larginine, L-glutamic acid, β-mercaptoethanol, dithiothreitol, and combinations
thereof.
9.

The method of any one of claims 1-8, wherein the one or more

recombinant spider silk proteins are selected from the group consisting of: M4,
M5, MaSP1, a MaSP1 analogue, MaSP2, an MaSP2 analogue, and combinations
thereof.
10.

The method of any one of claims 1-9, wherein the ratio of the one or

more recombinant spider silk proteins to water in the mixture is from 1:10 to
1:2.
11.

The method of any one of claims 1-10, further comprising obtaining a

recombinant spider silk protein fiber from the mixture.
12.
fiber.

The method of any one of claims 1-11, further comprising stretching the

151

13.

A recombinant spider silk protein material prepared according to any one

of claims 1-12, having the form of a hydrogel, lyogel, film, coating, foam, fiber,
and combinations thereof.
14.

An aqueous solution of recombinant spider silk proteins, comprising: one

or more recombinant spider silk proteins and water, wherein the amount of the
one or more recombinant spider silk proteins is greater than about 2% w/v.
15.

The aqueous solution of claim 14, wherein the amount of the one or

more recombinant spider silk proteins is less than about 50% w/v.
16.

The aqueous solution of any one of claims 14 and 15, further comprising

one or more additives for reducing gel formation.
17. The aqueous solution of claim 16, wherein the one or more additives are
selected from the group consisting of: an acid, a base, free amino acids,
surfactants, and combinations thereof.
18.

The aqueous solution of claim 16, wherein the one or more additives are

selected from the group consisting of: propionic acid, formic acid, acetic acid,
ammonium hydroxide, L-arginine, L-glutamic acid, β-mercaptoethanol,
dithiothreitol, and combinations thereof.
It will be appreciated that variations of the above-disclosed and other features
and functions, or alternatives thereof, may be desirably combined into many other
different systems or applications. Also, various presently unforeseen or unanticipated
alternatives, modifications, variations or improvements therein may be subsequently
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made by those skilled in the art, and are also intended to be encompassed by the
following claims.
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WHAT IS CLAIMED IS:

1.

A method of solubilizing one or more recombinant spider silk proteins in an

aqueous solution, comprising:
mixing the one or more recombinant spider silk proteins with water to form a mixture in
a sealed container;
heating the mixture to form a solution.
2.

The method of claim 1, wherein the heating is performed with microwave

irradiation.
3.

The method of claim 1, further comprising sonicating the mixture.

4.

The method of claim 1, further comprising sonicating the solution.

5.

The method of claim 1, further comprising centrifuging the solution.

6.

The method of claim 1, further comprising providing additives for reducing gel

formation in the solution.
7.

The method of claim 6, wherein the additives are selected from the group

consisting of: an acid, a base, free amino acids, surfactants, and combinations thereof.
8.

The method of claim 6, wherein the additives are selected from the group

consisting of: propionic acid, formic acid, acetic acid, ammonium hydroxide, L-arginine,
L-glutamic acid, β-mercaptoethanol, dithiothreitol, and combinations thereof.
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9.

The method of claim 1, wherein the one or more recombinant spider silk proteins

are selected from the group consisting of: M4, M5, MaSP1, a MaSP1 analogue, MaSP2,
an MaSP2 analogue, and combinations thereof.
10. The method of claim 1, wherein the ratio of the one or more recombinant spider
silk proteins to water in the mixture is from 1:10 to 1:2.
11. The method of claim 1, further comprising obtaining a recombinant spider silk
protein fiber from the mixture.
12. The method of claim 11, further comprising stretching the fiber.
13. A recombinant spider silk protein material prepared according to claim 12, having
the form of a hydrogel, lyogel, film, coating, foam, fiber, and combinations thereof.
14. An aqueous solution of recombinant spider silk proteins, comprising: one or more
recombinant spider silk proteins and water, wherein the amount of the one or more
recombinant spider silk proteins is greater than about 2% w/v.
15. The aqueous solution of claim 14, wherein the amount of the one or more
recombinant spider silk proteins is less than about 50% w/v.
16. The aqueous solution of claim 14, further comprising one or more additives for
reducing gel formation.
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17. The aqueous solution of claim 16, wherein the one or more additives are selected
from the group consisting of: an acid, a base, free amino acids, surfactants, and
combinations thereof.
18. The aqueous solution of claim 16, wherein the one or more additives are selected
from the group consisting of: propionic acid, formic acid, acetic acid, ammonium
hydroxide, L-arginine, L-glutamic acid, β-mercaptoethanol, dithiothreitol, and
combinations thereof.
19. A hydrogel made from mixing the one or more recombinant spider silk proteins
with water to form a mixture in a sealed container and heating the mixture to form a
solution.
20. The hydrogel of claim 19, further comprising an antibiotic material.
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ABSTRACT OF THE DISCLOSURE
A method for solubilizing recombinant spider silk proteins in an aqueous
solutions, where the method includes mixing recombinant spider silk proteins with
water to form a mixture and heating the mixture in a closed vessel to form a solution.
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